KAZIA THERAPEUTICS LTD (SEC Filing Page | XBRL Cloud Viewer | XBRL Instance)

Line Label Object Class Period Type Balance Report ElementName
1 1001 - Document - Document and Entity Information Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/DocumentandEntityInformation
2 Implied Table Table

*

*

 implied:Table
3 Document - Document and Entity Information [Abstract] Abstract kzia:DocumentandEntityInformationAbstract
4 Document Type Concept (Submission Type) For Period dei:DocumentType
5 Amendment Flag Concept (Yes/No) For Period dei:AmendmentFlag
6 Document Period End Date Concept (Date) For Period dei:DocumentPeriodEndDate
7 Document Fiscal Year Focus Concept (Year) For Period dei:DocumentFiscalYearFocus
8 Document Fiscal Period Focus Concept (Fiscal Period) For Period dei:DocumentFiscalPeriodFocus
9 Trading Symbol Concept (Text/String) For Period dei:TradingSymbol
10 Entity Registrant Name Concept (Text/String) For Period dei:EntityRegistrantName
11 Entity Central Index Key Concept (CIK Number) For Period dei:EntityCentralIndexKey
12 Current Fiscal Year End Date Concept (Month/Day) For Period dei:CurrentFiscalYearEndDate
13 Entity Well-known Seasoned Issuer Concept (Yes/No) For Period dei:EntityWellKnownSeasonedIssuer
14 Entity Current Reporting Status Concept (Yes/No) For Period dei:EntityCurrentReportingStatus
15 Entity Filer Category Concept (Filer Category) For Period dei:EntityFilerCategory
16 Entity Common Stock, Shares Outstanding Concept (Shares) As Of dei:EntityCommonStockSharesOutstanding
17 1003 - Statement - Consolidated statements of profit or loss and other comprehensive income Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/StatementOfComprehensiveIncomeProfitOrLossByNatureOfExpense-320000
18 Implied Table Table

*

*

 implied:Table
19 Profit or loss [abstract] Abstract ifrs-full:IncomeStatementAbstract
20 Revenue from continuing operations Concept (Monetary) For Period Credit ifrs-full:RevenueFromInterest
21 Other income Concept (Monetary) For Period Credit ifrs-full:OtherRevenue
22 Expenses Abstract ifrs-full:ExpenseByNatureAbstract
23 Research and development expense Concept (Monetary) For Period Debit ifrs-full:ResearchAndDevelopmentExpense
24 General and administrative expense Concept (Monetary) For Period Debit ifrs-full:SellingGeneralAndAdministrativeExpense
25 Loss on disposal of fixed assets Concept (Monetary) For Period Credit ifrs-full:GainsLossesOnDisposalsOfNoncurrentAssets
26 Fair value losses on financial assets at fair value through profit or loss Concept (Monetary) For Period Credit ifrs-full:GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLoss
27 Impairment of financial assets Concept (Monetary) For Period Debit ifrs-full:ImpairmentLossOnFinancialAssets
28 Loss on disposal of Cantx, Inc. after income tax expense Concept (Monetary) For Period Credit ifrs-full:GainsLossesOnDisposalsOfInvestments
29 Loss before income tax expense from continuing operations Concept (Monetary) For Period Credit ifrs-full:ProfitLossBeforeTax
30 Income tax benefit Concept (Monetary) For Period Debit ifrs-full:IncomeTaxExpenseContinuingOperations
31 Loss after income tax expense for the year Concept (Monetary) For Period Credit ifrs-full:ProfitLoss
32 Other comprehensive income Abstract ifrs-full:OtherComprehensiveIncomeAbstract
33 Items that may be reclassified subsequently to profit or loss Abstract ifrs-full:ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract
34 Gain (Loss) on the revaluation of available-for-sale financial assets, net of tax Concept (Monetary) For Period Credit ifrs-full:GainsLossesOnRemeasuringAvailableforsaleFinancialAssetsNetOfTax
35 Net exchange difference on translation of financial statements of foreign controlled entities, net of tax Concept (Monetary) For Period Credit ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation
36 Derecognition of foreign currency reserve relating to Cantx Inc. Concept (Monetary) For Period Credit ifrs-full:ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax
37 Other comprehensive income for the year, net of tax Concept (Monetary) For Period Credit ifrs-full:OtherComprehensiveIncome
38 Total comprehensive income for the year Concept (Monetary) For Period Credit ifrs-full:ComprehensiveIncome
39 Loss for the year is attributable to: Abstract ifrs-full:ProfitLossAttributableToAbstract
40 Non-controlling interest Concept (Monetary) For Period Credit ifrs-full:ProfitLossAttributableToNoncontrollingInterests
41 Owners of Kazia Therapeutics Limited Concept (Monetary) For Period Credit ifrs-full:ProfitLossAttributableToOwnersOfParent
42 Loss after income tax expense for the year Concept (Monetary) For Period Credit ifrs-full:ProfitLoss
43 Total comprehensive income for the year is attributable to: Abstract ifrs-full:ComprehensiveIncomeAttributableToAbstract
44 Non-controlling interest Concept (Monetary) For Period Credit ifrs-full:ComprehensiveIncomeAttributableToNoncontrollingInterests
45 Owners of Kazia Therapeutics Limited Concept (Monetary) For Period Credit ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent
46 Total comprehensive income for the year Concept (Monetary) For Period Credit ifrs-full:ComprehensiveIncome
47 Earnings per share for loss attributable to the owners of Kazia Therapeutics Limited Abstract ifrs-full:EarningsPerShareAbstract
48 Basic earnings per share Concept (Share) For Period ifrs-full:BasicEarningsLossPerShare
49 Diluted earnings per share Concept (Share) For Period ifrs-full:DilutedEarningsLossPerShare
50 1004 - Statement - Consolidated statements of financial position Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/StatementOfFinancialPositionCurrentNonCurrent-210000
51 Implied Table Table

*

*

 implied:Table
52 Statement of financial position [abstract] Abstract ifrs-full:StatementOfFinancialPositionAbstract
53 Assets Abstract ifrs-full:AssetsAbstract
54 Current assets Abstract ifrs-full:CurrentAssetsAbstract
55 Cash and cash equivalents Concept (Monetary) As Of Debit ifrs-full:CashAndCashEquivalents
56 Trade and other receivables Concept (Monetary) As Of Debit ifrs-full:TradeAndOtherCurrentReceivables
57 Income tax refund due Concept (Monetary) As Of Debit ifrs-full:CurrentTaxAssetsCurrent
58 Other Concept (Monetary) As Of Debit ifrs-full:OtherCurrentAssets
59 Total current assets Concept (Monetary) As Of Debit ifrs-full:CurrentAssets
60 Non-current assets Abstract ifrs-full:NoncurrentAssetsAbstract
61 Financial assets Concept (Monetary) As Of Debit ifrs-full:NoncurrentFinancialAssets
62 Property, plant and equipment Concept (Monetary) As Of Debit ifrs-full:PropertyPlantAndEquipment
63 Intangibles Concept (Monetary) As Of Debit ifrs-full:IntangibleAssetsOtherThanGoodwill
64 Total non-current assets Concept (Monetary) As Of Debit ifrs-full:NoncurrentAssets
65 Total assets Concept (Monetary) As Of Debit ifrs-full:Assets
66 Liabilities Abstract ifrs-full:LiabilitiesAbstract
67 Current liabilities Abstract ifrs-full:CurrentLiabilitiesAbstract
68 Trade and other payables Concept (Monetary) As Of Credit ifrs-full:TradeAndOtherCurrentPayables
69 Provisions Concept (Monetary) As Of Credit ifrs-full:CurrentProvisions
70 Deferred income Concept (Monetary) As Of Credit ifrs-full:DeferredIncome
71 Contingent consideration Concept (Monetary) As Of Credit kzia:ContingentConsiderationCurrent
72 Total current liabilities Concept (Monetary) As Of Credit ifrs-full:CurrentLiabilities
73 Non-Current liabilities Abstract ifrs-full:NoncurrentLiabilitiesAbstract
74 Deferred tax Concept (Monetary) As Of Credit ifrs-full:DeferredTaxLiabilities
75 Provisions Concept (Monetary) As Of Credit ifrs-full:NoncurrentProvisions
76 Trade and other payables Concept (Monetary) As Of Credit ifrs-full:NoncurrentPayables
77 Contingent consideration Concept (Monetary) As Of Credit kzia:ContingentConsiderationNoncurrent
78 Total non-current liabilities Concept (Monetary) As Of Credit ifrs-full:NoncurrentLiabilities
79 Total liabilities Concept (Monetary) As Of Credit ifrs-full:Liabilities
80 Net assets Concept (Monetary) As Of Debit ifrs-full:NetAssetsLiabilities
81 Equity Abstract ifrs-full:EquityAbstract
82 Contributed equity Concept (Monetary) As Of Credit ifrs-full:IssuedCapital
83 Other contributed equity Concept (Monetary) As Of Credit ifrs-full:OtherEquityInterest
84 Reserves Concept (Monetary) As Of Credit ifrs-full:OtherReserves
85 Accumulated losses Concept (Monetary) As Of Credit ifrs-full:RetainedEarnings
86 Equity attributable to the owners of Kazia Therapeutics Limited Concept (Monetary) As Of Credit ifrs-full:EquityAttributableToOwnersOfParent
87 Total equity Concept (Monetary) As Of Credit ifrs-full:Equity
88 1005 - Statement - Statements of changes in equity Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/StatementOfChangesInEquity-610000
89 Statement of changes in equity [table] Table

*

*

 ifrs-full:StatementOfChangesInEquityTable
90 Components of equity [axis] Axis ifrs-full:ComponentsOfEquityAxis
91 Equity [member] Member ifrs-full:EquityMember
92 Contributed equity [member] Member ifrs-full:IssuedCapitalMember
93 Other Contributed equity [member] Member ifrs-full:OtherEquityInterestMember
94 Reserves [member] Member ifrs-full:OtherReservesMember
95 Accumulated Losses [member] Member ifrs-full:RetainedEarningsMember
96 Non-controlling Interest [member] Member ifrs-full:NoncontrollingInterestsMember
97 Statement of changes in equity [line items] LineItems ifrs-full:StatementOfChangesInEquityLineItems
98 Beginning balance Concept (Monetary) As Of Credit ifrs-full:Equity
99 Loss after income tax expense for the year Concept (Monetary) For Period Credit ifrs-full:ProfitLoss
100 Other comprehensive income for the year, net of tax Concept (Monetary) For Period Credit ifrs-full:OtherComprehensiveIncome
101 Total comprehensive income for the year Concept (Monetary) For Period Credit ifrs-full:ComprehensiveIncome
102 Transactions with owners in their capacity as owners: Abstract kzia:TransactionsWithOwnersInTheirCapacityAsOwnersAbstract
103 Share issue costs Concept (Monetary) For Period Debit ifrs-full:ShareIssueRelatedCost
104 Derecognition of noncontrolling interest Concept (Monetary) For Period Debit kzia:DerecognitionOfNonControllingInterest
105 Transfers Concept (Monetary) For Period Credit ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesEquity
106 Derecognition of foreign currency reserves Concept (Monetary) For Period Debit kzia:DerecognitionOfForeignCurrencyReserve
107 Cancellation of share capital Concept (Monetary) For Period Debit ifrs-full:ReductionOfIssuedCapital
108 Conversion of convertible note Concept (Monetary) For Period Credit ifrs-full:IncreaseDecreaseThroughConversionOfConvertibleInstruments
109 Employee share-based payment options Concept (Monetary) For Period Credit kzia:IncreaseDecreaseThroughEmployeeSharebasedPaymentOptions
110 Share based payments Concept (Monetary) For Period Credit ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
111 Contributions of equity, net of transaction costs Concept (Monetary) For Period Credit ifrs-full:IssueOfEquity
112 Expired Options Concept (Monetary) For Period Credit kzia:IncreaseDecreaseThroughExpireOfOptions
113 Ending balance Concept (Monetary) As Of Credit ifrs-full:Equity
114 1006 - Statement - Consolidated statements of cash flows Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/StatementOfCashFlowsDirectMethod-510000
115 Implied Table Table

*

*

 implied:Table
116 Statement of cash flows [abstract] Abstract ifrs-full:StatementOfCashFlowsAbstract
117 Cash flows from operating activities Abstract ifrs-full:CashFlowsFromUsedInOperatingActivitiesAbstract
118 Loss before income tax expense for the year Concept (Monetary) For Period Credit ifrs-full:ProfitLoss
119 Adjustments for: Abstract ifrs-full:AdjustmentsForReconcileProfitLossAbstract
120 Depreciation and amortisation Concept (Monetary) For Period Debit ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense
121 Net loss on disposal of non-current assets Concept (Monetary) For Period Credit ifrs-full:GainsLossesOnDisposalsOfNoncurrentAssets
122 Impairment of property, plant and equipment Concept (Monetary) For Period ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment
123 Share-based payments Concept (Monetary) For Period Debit ifrs-full:AdjustmentsForSharebasedPayments
124 Foreign exchange differences Concept (Monetary) For Period Debit ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains
125 Shares issued for no consideration Concept (Monetary) For Period Credit kzia:SharesIssuedForNoConsideration
126 Gain on legal settlement Concept (Monetary) For Period Credit ifrs-full:GainsOnLitigationSettlements
127 Make good credit and rental adjustment Concept (Monetary) For Period Credit kzia:AdjustmentsForGainLossOnMakeGoodCreditAndRentalAdjustment
128 Net gain on disposal of CanTx, Inc. Concept (Monetary) For Period Credit ifrs-full:GainsLossesOnDisposalsOfInvestments
129 Interest income accrued Concept (Monetary) For Period Credit kzia:AdjustmentsForInterestIncomeAccrued
130 (Gain)/loss on contingent consideration Concept (Monetary) For Period Credit ifrs-full:ConsiderationPaidReceived
131 Fair value loss on financial assets at fair value through profit or loss Concept (Monetary) For Period Credit ifrs-full:GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLoss
132 Impairment of financial assets Concept (Monetary) For Period Debit ifrs-full:ImpairmentLossOnFinancialAssets
133 Cash flows from used in operations before changes in working capital Concept (Monetary) For Period ifrs-full:CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital
134 Change in operating assets and liabilities: Abstract kzia:AdjustmentsForNetChangesInOperatingAssetsAndLiabilitiesAbstract
135 Decrease/(increase) in trade and other receivables Concept (Monetary) For Period Debit ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables
136 Increase in income tax refund due Concept (Monetary) For Period Debit kzia:AdjustmentsForDecreaseIncreaseInIncomeTaxRefundDue
137 Increase in prepayments Concept (Monetary) For Period Debit kzia:AdjustmentsForDecreaseIncreaseInPrepayments
138 Decrease/(increase) in trade and other payables Concept (Monetary) For Period Debit ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables
139 (Decrease)/increase in other provisions Concept (Monetary) For Period Debit ifrs-full:AdjustmentsForProvisions
140 (Decrease) in deposit paid Concept (Monetary) For Period Debit kzia:AdjustmentsForIncreaseDecreaseInDepositPaid
141 Increase in deferred tax liability Concept (Monetary) For Period Debit kzia:AdjustmentsForIncreaseDecreaseInDeferredTaxLiabilities
142 Decrease in accrued revenue Concept (Monetary) For Period Debit ifrs-full:AdjustmentsForIncreaseDecreaseInDeferredIncome
143 Net cash used in operating activities Concept (Monetary) For Period ifrs-full:CashFlowsFromUsedInOperatingActivities
144 Cash flows from investing activities Abstract ifrs-full:CashFlowsFromUsedInInvestingActivitiesAbstract
145 Payment for purchase of business, net of cash acquired Concept (Monetary) For Period Credit ifrs-full:CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities
146 Payments for property, plant and equipment Concept (Monetary) For Period Credit ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
147 Payments for intangibles Concept (Monetary) For Period Credit ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities
148 Proceeds from disposal of property, plant and equipment Concept (Monetary) For Period Debit ifrs-full:ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
149 Proceeds from legal settlement Concept (Monetary) For Period Debit kzia:ProceedsFromLegalSettlement
150 Net cash used in investing activities Concept (Monetary) For Period Debit ifrs-full:CashFlowsFromUsedInInvestingActivities
151 Cash flows from financing activities Abstract ifrs-full:CashFlowsFromUsedInFinancingActivitiesAbstract
152 Proceeds from issue of shares Concept (Monetary) For Period Debit ifrs-full:ProceedsFromIssuingShares
153 Share issue transaction costs Concept (Monetary) For Period Credit ifrs-full:PaymentsForShareIssueCosts
154 Net cash from financing activities Concept (Monetary) For Period Debit ifrs-full:CashFlowsFromUsedInFinancingActivities
155 Net (decrease) in cash and cash equivalents Concept (Monetary) For Period Debit ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges
156 Cash and cash equivalents at the beginning of the financial year Concept (Monetary) As Of Debit ifrs-full:CashAndCashEquivalents
157 Effects of exchange rate changes on cash Concept (Monetary) For Period Debit ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents
158 Cash and cash equivalents at the end of the financial year Concept (Monetary) As Of Debit ifrs-full:CashAndCashEquivalents
159 1007 - Disclosure - General information Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfGeneralInformationAboutFinancialStatementsExplanatory
160 Implied Table Table

*

*

 implied:Table
161 Text block1 [abstract] Abstract kzia:TextBlock1Abstract
162 General information Concept (Text Block (HTML)) For Period ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory
163 1008 - Disclosure - Significant accounting policies Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory
164 Implied Table Table

*

*

 implied:Table
165 Text block1 [abstract] Abstract kzia:TextBlock1Abstract
166 Significant accounting policies Concept (Text Block (HTML)) For Period ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory
167 1009 - Disclosure - Critical accounting judgements, estimates and assumptions Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfAccountingJudgementsAndEstimatesExplanatory
168 Implied Table Table

*

*

 implied:Table
169 Text block1 [abstract] Abstract kzia:TextBlock1Abstract
170 Critical accounting judgements, estimates and assumptions Concept (Text Block (HTML)) For Period ifrs-full:DisclosureOfAccountingJudgementsAndEstimatesExplanatory
171 1010 - Disclosure - Operating segments Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfOperatingSegmentsExplanatory
172 Implied Table Table

*

*

 implied:Table
173 Text block1 [abstract] Abstract kzia:TextBlock1Abstract
174 Operating segments Concept (Text Block (HTML)) For Period ifrs-full:DisclosureOfOperatingSegmentsExplanatory
175 1011 - Disclosure - Revenue Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfRevenueExplanatory
176 Implied Table Table

*

*

 implied:Table
177 Text block1 [abstract] Abstract kzia:TextBlock1Abstract
178 Revenue Concept (Text Block (HTML)) For Period ifrs-full:DisclosureOfRevenueExplanatory
179 1012 - Disclosure - Other income Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfOtherOperatingIncomeExplanatory
180 Implied Table Table

*

*

 implied:Table
181 Text block1 [abstract] Abstract kzia:TextBlock1Abstract
182 Other income Concept (Text Block (HTML)) For Period ifrs-full:DisclosureOfOtherOperatingIncomeExplanatory
183 1013 - Disclosure - Expenses Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfExpensesExplanatory
184 Implied Table Table

*

*

 implied:Table
185 Text block1 [abstract] Abstract kzia:TextBlock1Abstract
186 Expenses Concept (Text Block (HTML)) For Period ifrs-full:DisclosureOfExpensesExplanatory
187 1014 - Disclosure - Income tax benefit Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfIncomeTaxExplanatory
188 Implied Table Table

*

*

 implied:Table
189 Text block1 [abstract] Abstract kzia:TextBlock1Abstract
190 Income tax benefit Concept (Text Block (HTML)) For Period ifrs-full:DisclosureOfIncomeTaxExplanatory
191 1015 - Disclosure - Current assets - cash and cash equivalents Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfCashAndCashEquivalentsExplanatory
192 Implied Table Table

*

*

 implied:Table
193 Text block1 [abstract] Abstract kzia:TextBlock1Abstract
194 Current assets - cash and cash equivalents Concept (Text Block (HTML)) For Period ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory
195 1016 - Disclosure - Current assets - trade and other receivables Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfTradeAndOtherReceivablesExplanatory
196 Implied Table Table

*

*

 implied:Table
197 Text block1 [abstract] Abstract kzia:TextBlock1Abstract
198 Current assets - trade and other receivables Concept (Text Block (HTML)) For Period ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory
199 1017 - Disclosure - Current assets - income tax refund due Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfCurrentAssetsIncomeTaxRefundDueExplanatory
200 Implied Table Table

*

*

 implied:Table
201 Text block1 [abstract] Abstract kzia:TextBlock1Abstract
202 Current assets - income tax refund due Concept (Text Block (HTML)) For Period kzia:DisclosureOfCurrentAssetsIncomeTaxRefundDueExplanatory
203 1018 - Disclosure - Current assets - other Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfOtherCurrentAssetsExplanatory
204 Implied Table Table

*

*

 implied:Table
205 Text block1 [abstract] Abstract kzia:TextBlock1Abstract
206 Current assets - other Concept (Text Block (HTML)) For Period ifrs-full:DisclosureOfOtherCurrentAssetsExplanatory
207 1019 - Disclosure - Non-current assets - Financial assets Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfAvailableforsaleAssetsExplanatory
208 Implied Table Table

*

*

 implied:Table
209 Text block1 [abstract] Abstract kzia:TextBlock1Abstract
210 Non-current assets - Financial assets Concept (Text Block (HTML)) For Period ifrs-full:DisclosureOfAvailableforsaleAssetsExplanatory
211 1020 - Disclosure - Non-current assets - property, plant and equipment Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfPropertyPlantAndEquipmentExplanatory
212 Implied Table Table

*

*

 implied:Table
213 Text block1 [abstract] Abstract kzia:TextBlock1Abstract
214 Non-current assets - property, plant and equipment Concept (Text Block (HTML)) For Period ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory
215 1021 - Disclosure - Non-current assets - intangibles Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfIntangibleAssetsExplanatory
216 Implied Table Table

*

*

 implied:Table
217 Text block1 [abstract] Abstract kzia:TextBlock1Abstract
218 Non-current assets - intangibles Concept (Text Block (HTML)) For Period ifrs-full:DisclosureOfIntangibleAssetsExplanatory
219 1022 - Disclosure - Trade and other payables Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfTradeAndOtherPayablesExplanatory
220 Statement [table] Table

*

*

 us-gaap:StatementTable
221 Maturity [axis] Axis ifrs-full:MaturityAxis
222 Aggregated time bands [member] Member ifrs-full:AggregatedTimeBandsMember
223 1 year or less [member] Member ifrs-full:NotLaterThanOneYearMember
224 Statement [line items] LineItems us-gaap:StatementLineItems
225 Trade and other payables Concept (Text Block (HTML)) For Period ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory
226 1023 - Disclosure - Provisions Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfProvisionsExplanatory
227 Statement [table] Table

*

*

 us-gaap:StatementTable
228 Maturity [axis] Axis ifrs-full:MaturityAxis
229 Aggregated time bands [member] Member ifrs-full:AggregatedTimeBandsMember
230 1 year or less [member] Member ifrs-full:NotLaterThanOneYearMember
231 Statement [line items] LineItems us-gaap:StatementLineItems
232 Provisions Concept (Text Block (HTML)) For Period ifrs-full:DisclosureOfProvisionsExplanatory
233 1024 - Disclosure - Contingent consideration Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfContingentConsiderationLiabilitiesExplanatory
234 Statement [table] Table

*

*

 us-gaap:StatementTable
235 Maturity [axis] Axis ifrs-full:MaturityAxis
236 Aggregated time bands [member] Member ifrs-full:AggregatedTimeBandsMember
237 1 year or less [member] Member ifrs-full:NotLaterThanOneYearMember
238 Later than one year [member] Member ifrs-full:LaterThanOneYearMember
239 Statement [line items] LineItems us-gaap:StatementLineItems
240 Contingent consideration Concept (Text Block (HTML)) For Period kzia:DisclosureOfContingentConsiderationLiabilitiesExplanatory
241 1025 - Disclosure - Non-current liabilities - deferred tax Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfDeferredTaxesExplanatory
242 Implied Table Table

*

*

 implied:Table
243 Text block1 [abstract] Abstract kzia:TextBlock1Abstract
244 Non-current liabilities - deferred tax Concept (Text Block (HTML)) For Period ifrs-full:DisclosureOfDeferredTaxesExplanatory
245 1026 - Disclosure - Equity - contributed equity Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfIssuedCapitalExplanatory
246 Implied Table Table

*

*

 implied:Table
247 Text block1 [abstract] Abstract kzia:TextBlock1Abstract
248 Equity - contributed equity Concept (Text Block (HTML)) For Period ifrs-full:DisclosureOfIssuedCapitalExplanatory
249 1027 - Disclosure - Equity - Other contributed equity Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfOtherEquityExplanatory
250 Implied Table Table

*

*

 implied:Table
251 Text block1 [abstract] Abstract kzia:TextBlock1Abstract
252 Equity - Other contributed equity Concept (Text Block (HTML)) For Period kzia:DisclosureOfOtherEquityExplanatory
253 1028 - Disclosure - Equity - reserves Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfReservesAndOtherEquityInterestExplanatory
254 Implied Table Table

*

*

 implied:Table
255 Text block1 [abstract] Abstract kzia:TextBlock1Abstract
256 Equity - reserves Concept (Text Block (HTML)) For Period ifrs-full:DisclosureOfReservesAndOtherEquityInterestExplanatory
257 1029 - Disclosure - Equity - dividends Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfDividendsExplanatory
258 Implied Table Table

*

*

 implied:Table
259 Text block1 [abstract] Abstract kzia:TextBlock1Abstract
260 Equity - dividends Concept (Text Block (HTML)) For Period ifrs-full:DisclosureOfDividendsExplanatory
261 1030 - Disclosure - Financial instruments Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfFinancialInstrumentsExplanatory
262 Implied Table Table

*

*

 implied:Table
263 Text block1 [abstract] Abstract kzia:TextBlock1Abstract
264 Financial instruments Concept (Text Block (HTML)) For Period ifrs-full:DisclosureOfFinancialInstrumentsExplanatory
265 1031 - Disclosure - Fair value measurement Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfFairValueMeasurementExplanatory
266 Implied Table Table

*

*

 implied:Table
267 Text block1 [abstract] Abstract kzia:TextBlock1Abstract
268 Fair value measurement Concept (Text Block (HTML)) For Period ifrs-full:DisclosureOfFairValueMeasurementExplanatory
269 1032 - Disclosure - Key management personnel disclosures Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfInformationAboutKeyManagementPersonnelExplanatory
270 Implied Table Table

*

*

 implied:Table
271 Text block1 [abstract] Abstract kzia:TextBlock1Abstract
272 Key management personnel disclosures Concept (Text Block (HTML)) For Period ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory
273 1033 - Disclosure - Remuneration of auditors Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfAuditorsRemunerationExplanatory
274 Implied Table Table

*

*

 implied:Table
275 Text block1 [abstract] Abstract kzia:TextBlock1Abstract
276 Remuneration of auditors Concept (Text Block (HTML)) For Period ifrs-full:DisclosureOfAuditorsRemunerationExplanatory
277 1034 - Disclosure - Contingent liabilities Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfContingentLiabilitiesExplanatory
278 Implied Table Table

*

*

 implied:Table
279 Text block1 [abstract] Abstract kzia:TextBlock1Abstract
280 Contingent liabilities Concept (Text Block (HTML)) For Period ifrs-full:DisclosureOfContingentLiabilitiesExplanatory
281 1035 - Disclosure - Commitments Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfCommitmentsExplanatory
282 Implied Table Table

*

*

 implied:Table
283 Text block1 [abstract] Abstract kzia:TextBlock1Abstract
284 Commitments Concept (Text Block (HTML)) For Period ifrs-full:DisclosureOfCommitmentsExplanatory
285 1036 - Disclosure - Related party transactions Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfRelatedPartyExplanatory
286 Implied Table Table

*

*

 implied:Table
287 Text block1 [abstract] Abstract kzia:TextBlock1Abstract
288 Related party transactions Concept (Text Block (HTML)) For Period ifrs-full:DisclosureOfRelatedPartyExplanatory
289 1037 - Disclosure - Parent entity information Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfInterimFinancialReportingExplanatory
290 Implied Table Table

*

*

 implied:Table
291 Text block1 [abstract] Abstract kzia:TextBlock1Abstract
292 Parent entity information Concept (Text Block (HTML)) For Period ifrs-full:DisclosureOfInterimFinancialReportingExplanatory
293 1038 - Disclosure - Business combinations Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfBusinessCombinationsExplanatory
294 Implied Table Table

*

*

 implied:Table
295 Text block1 [abstract] Abstract kzia:TextBlock1Abstract
296 Business combinations Concept (Text Block (HTML)) For Period ifrs-full:DisclosureOfBusinessCombinationsExplanatory
297 1039 - Disclosure - Interests in subsidiaries Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfInterestsInSubsidiariesExplanatory
298 Implied Table Table

*

*

 implied:Table
299 Text block1 [abstract] Abstract kzia:TextBlock1Abstract
300 Interests in subsidiaries Concept (Text Block (HTML)) For Period ifrs-full:DisclosureOfInterestsInSubsidiariesExplanatory
301 1040 - Disclosure - Deed of cross guarantee Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfDeedOfCrossGuaranteeExplanatory
302 Implied Table Table

*

*

 implied:Table
303 Text block1 [abstract] Abstract kzia:TextBlock1Abstract
304 Deed of cross guarantee Concept (Text Block (HTML)) For Period kzia:DisclosureOfDeedOfCrossGuaranteeExplanatory
305 1041 - Disclosure - Events after the reporting period Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfEventsAfterReportingPeriodExplanatory
306 Implied Table Table

*

*

 implied:Table
307 Text block1 [abstract] Abstract kzia:TextBlock1Abstract
308 Events after the reporting period Concept (Text Block (HTML)) For Period ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory
309 1042 - Disclosure - Earnings per share Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfEarningsPerShareExplanatory
310 Implied Table Table

*

*

 implied:Table
311 Text block1 [abstract] Abstract kzia:TextBlock1Abstract
312 Earnings per share Concept (Text Block (HTML)) For Period ifrs-full:DisclosureOfEarningsPerShareExplanatory
313 1043 - Disclosure - Share-based payments Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfSharebasedPaymentArrangementsExplanatory
314 Implied Table Table

*

*

 implied:Table
315 Text block1 [abstract] Abstract kzia:TextBlock1Abstract
316 Share-based payments Concept (Text Block (HTML)) For Period ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory
317 1044 - Disclosure - Settlement of legal proceedings Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfLegalProceedingsExplanatory
318 Implied Table Table

*

*

 implied:Table
319 Text block1 [abstract] Abstract kzia:TextBlock1Abstract
320 Settlement of legal proceedings Concept (Text Block (HTML)) For Period kzia:DisclosureOfLegalProceedingsExplanatory
321 1045 - Disclosure - Significant accounting policies (Policies) Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfSummaryOfSignificantAccountingPoliciesExplanatoryPolicies
322 Implied Table Table

*

*

 implied:Table
323 Text block1 [abstract] Abstract kzia:TextBlock1Abstract
324 New or amended Accounting Standards and Interpretations adopted Concept (Text Block (HTML)) For Period kzia:DescriptionOfAccountingPolicyForNewRevisedOrAmendingAccountingStandardsAndInterpretationsAdoptedExplanatory
325 Going concern Concept (Text Block (HTML)) For Period ifrs-full:DisclosureOfGoingConcernExplanatory
326 Basis of preparation Concept (Text Block (HTML)) For Period ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory
327 Parent entity information Concept (Text Block (HTML)) For Period kzia:DescriptionOfParentEntityInformationExplanatory
328 Principles of consolidation Concept (Text Block (HTML)) For Period ifrs-full:DisclosureOfBasisOfConsolidationExplanatory
329 Operating segments Concept (Text Block (HTML)) For Period ifrs-full:DescriptionOfAccountingPolicyForSegmentReportingExplanatory
330 Foreign currency translation Concept (Text Block (HTML)) For Period ifrs-full:DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory
331 Revenue recognition Concept (Text Block (HTML)) For Period ifrs-full:DescriptionOfAccountingPolicyForRecognitionOfRevenue
332 Grant Income Concept (Text Block (HTML)) For Period kzia:DescriptionOfAccountingPolicyForResearchCostsAndAdvertisingExpenseExplanatory
333 Income tax Concept (Text Block (HTML)) For Period ifrs-full:DescriptionOfAccountingPolicyForIncomeTaxExplanatory
334 Current and non-current classification Concept (Text Block (HTML)) For Period kzia:DescriptionOfAccountingPolicyForCurrentAndNoncurrentClassificationExplanatory
335 Cash and cash equivalents Concept (Text Block (HTML)) For Period ifrs-full:DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents
336 Trade and other receivables Concept (Text Block (HTML)) For Period ifrs-full:DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory
337 Investments and other financial assets Concept (Text Block (HTML)) For Period ifrs-full:DescriptionOfAccountingPolicyForFinancialAssetsExplanatory
338 Property, plant and equipment Concept (Text Block (HTML)) For Period ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory
339 Research and development Concept (Text Block (HTML)) For Period ifrs-full:DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory
340 Leases Concept (Text Block (HTML)) For Period ifrs-full:DescriptionOfAccountingPolicyForLeasesExplanatory
341 Intangible assets Concept (Text Block (HTML)) For Period ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory
342 Impairment of non-financial assets Concept (Text Block (HTML)) For Period ifrs-full:DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory
343 Trade and other payables Concept (Text Block (HTML)) For Period ifrs-full:DescriptionOfAccountingPolicyForTradeAndOtherPayablesExplanatory
344 Compound financial instruments Concept (Text Block (HTML)) For Period ifrs-full:DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory
345 Provisions Concept (Text Block (HTML)) For Period ifrs-full:DescriptionOfAccountingPolicyForProvisionsExplanatory
346 Employee benefits Concept (Text Block (HTML)) For Period ifrs-full:DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory
347 Finance costs Concept (Text Block (HTML)) For Period ifrs-full:DescriptionOfAccountingPolicyForFinanceCostsExplanatory
348 Fair value measurement Concept (Text Block (HTML)) For Period ifrs-full:DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory
349 Issued capital Concept (Text Block (HTML)) For Period ifrs-full:DescriptionOfAccountingPolicyForIssuedCapitalExplanatory
350 Earnings per share Concept (Text Block (HTML)) For Period ifrs-full:DescriptionOfAccountingPolicyForEarningsPerShareExplanatory
351 Goods and Services Tax ('GST') and other similar taxes Concept (Text Block (HTML)) For Period ifrs-full:DescriptionOfAccountingPolicyForTaxesOtherThanIncomeTaxExplanatory
352 New Accounting Standards and Interpretations not yet mandatory or early adopted Concept (Text Block (HTML)) For Period kzia:DescriptionOfAccountingPolicyForNewAccountingStandardsAndInterpretationsNotYetMandatoryOrEarlyAdoptedExplanatory
353 1046 - Disclosure - Revenue (Tables) Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfRevenueExplanatoryTables
354 Implied Table Table

*

*

 implied:Table
355 Text block1 [abstract] Abstract kzia:TextBlock1Abstract
356 Summary of revenue Concept (Text Block (HTML)) For Period kzia:DisclosureOfDetailedInformationAboutRevenueExplanatory
357 1047 - Disclosure - Other income (Tables) Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfOtherOperatingIncomeExplanatoryTables
358 Implied Table Table

*

*

 implied:Table
359 Text block1 [abstract] Abstract kzia:TextBlock1Abstract
360 Summary of other income Concept (Text Block (HTML)) For Period kzia:DisclosureOfDetailedInformationAboutOtherIncomeExplanatory
361 1048 - Disclosure - Expenses (Tables) Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfExpensesExplanatoryTables
362 Implied Table Table

*

*

 implied:Table
363 Text block1 [abstract] Abstract kzia:TextBlock1Abstract
364 Summary of expenses Concept (Text Block (HTML)) For Period ifrs-full:DisclosureOfExpensesByNatureExplanatory
365 1049 - Disclosure - Income tax benefit (Tables) Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfIncomeTaxExplanatoryTables
366 Implied Table Table

*

*

 implied:Table
367 Text block1 [abstract] Abstract kzia:TextBlock1Abstract
368 Summary of income tax benefit Concept (Text Block (HTML)) For Period kzia:DisclosureOfDetailedInformationAboutIncomeTaxExplanatory
369 1050 - Disclosure - Current assets - cash and cash equivalents (Tables) Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfCashAndCashEquivalentsExplanatoryTables
370 Implied Table Table

*

*

 implied:Table
371 Text block1 [abstract] Abstract kzia:TextBlock1Abstract
372 Summary of cash and cash equivalents Concept (Text Block (HTML)) For Period kzia:DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory
373 1051 - Disclosure - Current assets - trade and other receivables (Tables) Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfTradeAndOtherReceivablesExplanatoryTables
374 Statement [table] Table

*

*

 us-gaap:StatementTable
375 Classes of financial assets [axis] Axis ifrs-full:ClassesOfFinancialAssetsAxis
376 Financial assets, class [member] Member ifrs-full:FinancialAssetsMember
377 Trade receivables [member] Member ifrs-full:TradeReceivablesMember
378 Statement [line items] LineItems us-gaap:StatementLineItems
379 Summary of current assets - trade and other receivables Concept (Text Block (HTML)) For Period kzia:DisclosureOfDetailedInformationAboutTradeAndOtherReceivablesExplanatory
380 Summary of ageing of impaired receivables Concept (Text Block (HTML)) For Period ifrs-full:AnalysisOfFinancialAssetsThatAreIndividuallyDeterminedToBeImpaired
381 1052 - Disclosure - Current assets - income tax refund due (Tables) Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfCurrentAssetsIncomeTaxRefundDueExplanatoryTables
382 Implied Table Table

*

*

 implied:Table
383 Text block1 [abstract] Abstract kzia:TextBlock1Abstract
384 Summary of current assets - income tax refund due Concept (Text Block (HTML)) For Period kzia:DisclosureOfDetailedInformationAboutCurrentAssetsIncomeTaxRefundDueExplanatory
385 1053 - Disclosure - Current assets - other (Tables) Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfOtherCurrentAssetsExplanatoryTables
386 Implied Table Table

*

*

 implied:Table
387 Text block1 [abstract] Abstract kzia:TextBlock1Abstract
388 Summary of current assets - other Concept (Text Block (HTML)) For Period kzia:DisclosureOfDetailedInformationAboutOtherCurrentAssetsExplanatory
389 1054 - Disclosure - Non-current assets - Financial assets (Tables) Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfAvailableforsaleAssetsExplanatoryTables
390 Implied Table Table

*

*

 implied:Table
391 Text block1 [abstract] Abstract kzia:TextBlock1Abstract
392 Summary of non-current assets - financial assets Concept (Text Block (HTML)) For Period kzia:DisclosureOfDetailedInformationAboutAvailableforsaleFinancialAssetsExplanatory
393 1055 - Disclosure - Non-current assets - property, plant and equipment (Tables) Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfPropertyPlantAndEquipmentExplanatoryTables
394 Implied Table Table

*

*

 implied:Table
395 Text block1 [abstract] Abstract kzia:TextBlock1Abstract
396 Summary of non-current assets - property, plant and equipment Concept (Text Block (HTML)) For Period ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory
397 Summary of reconciliations of property, plant and equipment Concept (Text Block (HTML)) For Period kzia:DisclosureOfReconciliationOfChangesPropertyPlantAndEquipmentExplanatory
398 1056 - Disclosure - Non-current assets - intangibles (Tables) Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfIntangibleAssetsExplanatoryTables
399 Implied Table Table

*

*

 implied:Table
400 Text block1 [abstract] Abstract kzia:TextBlock1Abstract
401 Summary of non-current assets - intangibles Concept (Text Block (HTML)) For Period ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory
402 Summary of reconciliations of intangibles Concept (Text Block (HTML)) For Period kzia:DisclosureOfReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillExplanatory
403 1057 - Disclosure - Trade and other payables (Tables) Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfTradeAndOtherPayablesExplanatoryTables
404 Statement [table] Table

*

*

 us-gaap:StatementTable
405 Maturity [axis] Axis ifrs-full:MaturityAxis
406 Aggregated time bands [member] Member ifrs-full:AggregatedTimeBandsMember
407 1 year or less [member] Member ifrs-full:NotLaterThanOneYearMember
408 Statement [line items] LineItems us-gaap:StatementLineItems
409 Summary of trade and other payables Concept (Text Block (HTML)) For Period kzia:DisclosureOfDetailedInformationAboutTradeAndOtherPayablesExplanatory
410 1058 - Disclosure - Provisions (Tables) Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfProvisionsExplanatoryTables
411 Statement [table] Table

*

*

 us-gaap:StatementTable
412 Maturity [axis] Axis ifrs-full:MaturityAxis
413 Aggregated time bands [member] Member ifrs-full:AggregatedTimeBandsMember
414 1 year or less [member] Member ifrs-full:NotLaterThanOneYearMember
415 Statement [line items] LineItems us-gaap:StatementLineItems
416 Summary of provisions Concept (Text Block (HTML)) For Period kzia:DisclosureOfDetailedInformationAboutProvisionsExplanatory
417 1059 - Disclosure - Contingent consideration (Tables) Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfContingentConsiderationLiabilitiesExplanatoryTables
418 Statement [table] Table

*

*

 us-gaap:StatementTable
419 Maturity [axis] Axis ifrs-full:MaturityAxis
420 Aggregated time bands [member] Member ifrs-full:AggregatedTimeBandsMember
421 1 year or less [member] Member ifrs-full:NotLaterThanOneYearMember
422 Later than one year [member] Member ifrs-full:LaterThanOneYearMember
423 Statement [line items] LineItems us-gaap:StatementLineItems
424 Summary of liabilities - contingent consideration Concept (Text Block (HTML)) For Period kzia:DisclosureOfDetailedInformationAboutContingentConsiderationLiabilitiesExplanatory
425 1060 - Disclosure - Non-current liabilities - deferred tax (Tables) Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfDeferredTaxesExplanatoryTables
426 Implied Table Table

*

*

 implied:Table
427 Text block1 [abstract] Abstract kzia:TextBlock1Abstract
428 Summary of non-current liabilities - deferred tax Concept (Text Block (HTML)) For Period kzia:DisclosureOfDetailedInformationAboutDeferredTaxesExplanatory
429 1061 - Disclosure - Equity - contributed equity (Tables) Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfIssuedCapitalExplanatoryTables
430 Implied Table Table

*

*

 implied:Table
431 Text block1 [abstract] Abstract kzia:TextBlock1Abstract
432 Summary of equity - contributed equity Concept (Text Block (HTML)) For Period kzia:DisclosureOfDetailedInformationAboutIssuedCapitalExplanatory
433 Summary of movements in ordinary share capital Concept (Text Block (HTML)) For Period kzia:DisclosureOfDetailedInformationAboutMovementInOrdinaryShareCapitalExplanatory
434 1062 - Disclosure - Equity - Other contributed equity (Tables) Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfOtherEquityExplanatoryTables
435 Implied Table Table

*

*

 implied:Table
436 Text block1 [abstract] Abstract kzia:TextBlock1Abstract
437 Summary of equity - other contributed equity Concept (Text Block (HTML)) For Period kzia:DisclosureOfDetailedInformationAboutOtherEquityExplanatory
438 1063 - Disclosure - Financial instruments (Tables) Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfFinancialInstrumentsExplanatoryTables
439 Statement [table] Table

*

*

 us-gaap:StatementTable
440 Types of risks [axis] Axis ifrs-full:TypesOfRisksAxis
441 Risks [member] Member ifrs-full:TypesOfRisksMember
442 Foreign currency risk [member] Member ifrs-full:CurrencyRiskMember
443 Statement [line items] LineItems us-gaap:StatementLineItems
444 Summary of foreign currency risk Concept (Text Block (HTML)) For Period ifrs-full:DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsExplanatory
445 Summary of foreign currency risk sensitivity Concept (Text Block (HTML)) For Period ifrs-full:SensitivityAnalysisForEachTypeOfMarketRisk
446 Summary of variable interest rate balances Concept (Text Block (HTML)) For Period ifrs-full:DisclosureOfFinancialInstrumentsByTypeOfInterestRateExplanatory
447 Summary of remaining contractual maturities of financial instrument liabilities Concept (Text Block (HTML)) For Period ifrs-full:MaturityAnalysisForNonderivativeFinancialLiabilities
448 1064 - Disclosure - Fair value measurement (Tables) Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfFairValueMeasurementExplanatoryTables
449 Implied Table Table

*

*

 implied:Table
450 Text block1 [abstract] Abstract kzia:TextBlock1Abstract
451 Summary of assets and liabilities, measured or disclosed at fair value Concept (Text Block (HTML)) For Period kzia:DisclosureOfDetailedInformationAboutFairValueMeasurementExplanatory
452 1065 - Disclosure - Key management personnel disclosures (Tables) Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfInformationAboutKeyManagementPersonnelExplanatoryTables
453 Implied Table Table

*

*

 implied:Table
454 Text block1 [abstract] Abstract kzia:TextBlock1Abstract
455 Summary of compensation made to directors and other members of key management personnel Concept (Text Block (HTML)) For Period kzia:DisclosureOfDetailedInformationAboutKeyManagementPersonnelExplanatory
456 1066 - Disclosure - Remuneration of auditors (Tables) Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfAuditorsRemunerationExplanatoryTables
457 Implied Table Table

*

*

 implied:Table
458 Text block1 [abstract] Abstract kzia:TextBlock1Abstract
459 Summary of remuneration of auditors Concept (Text Block (HTML)) For Period kzia:DisclosureOfDetailedInformationAboutAuditorsRemunerationExplanatory
460 1067 - Disclosure - Commitments (Tables) Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfCommitmentsExplanatoryTables
461 Implied Table Table

*

*

 implied:Table
462 Text block1 [abstract] Abstract kzia:TextBlock1Abstract
463 Summary of lease commitments - operating Concept (Text Block (HTML)) For Period ifrs-full:DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory
464 1068 - Disclosure - Related party transactions (Tables) Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfRelatedPartyExplanatoryTables
465 Implied Table Table

*

*

 implied:Table
466 Text block1 [abstract] Abstract kzia:TextBlock1Abstract
467 Summary of transactions occurred with related parties Concept (Text Block (HTML)) For Period ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory
468 1069 - Disclosure - Parent entity information (Tables) Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfInterimFinancialReportingExplanatoryTables
469 Implied Table Table

*

*

 implied:Table
470 Text block1 [abstract] Abstract kzia:TextBlock1Abstract
471 Parent entity financial information Concept (Text Block (HTML)) For Period kzia:DisclosureOfParentEntityFinancialInformationExplanatory
472 1070 - Disclosure - Business combinations (Tables) Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfBusinessCombinationsExplanatoryTables
473 Implied Table Table

*

*

 implied:Table
474 Text block1 [abstract] Abstract kzia:TextBlock1Abstract
475 Summary of details of acquisition Concept (Text Block (HTML)) For Period ifrs-full:DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory
476 Summary of range of outcomes of contingent consideration Concept (Text Block (HTML)) For Period ifrs-full:DisclosureOfContingentLiabilitiesInBusinessCombinationExplanatory
477 1071 - Disclosure - Interests in subsidiaries (Tables) Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfInterestsInSubsidiariesExplanatoryTables
478 Implied Table Table

*

*

 implied:Table
479 Text block1 [abstract] Abstract kzia:TextBlock1Abstract
480 Summary of interest in subsidiaries Concept (Text Block (HTML)) For Period ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory
481 1072 - Disclosure - Earnings per share (Tables) Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfEarningsPerShareExplanatoryTables
482 Implied Table Table

*

*

 implied:Table
483 Text block1 [abstract] Abstract kzia:TextBlock1Abstract
484 Summary of earnings per share Concept (Text Block (HTML)) For Period ifrs-full:EarningsPerShareExplanatory
485 1073 - Disclosure - Share-based payments (Tables) Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfSharebasedPaymentArrangementsExplanatoryTables
486 Implied Table Table

*

*

 implied:Table
487 Text block1 [abstract] Abstract kzia:TextBlock1Abstract
488 Summary of share-based payments Concept (Text Block (HTML)) For Period ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory
489 Summary of valuation for each tranche of options Concept (Text Block (HTML)) For Period ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory
490 1074 - Disclosure - Significant accounting policies - Additional Information (Detail) Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/DisclosureSignificantAccountingPoliciesAdditionalInformation
491 Disclosure of summary of significant accounting policies [table] Table

*

*

 kzia:DisclosureOfSummaryOfSignificantAccountingPoliciesTable
492 Classes of property, plant and equipment [axis] Axis ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis
493 Property, plant and equipment [member] Member ifrs-full:PropertyPlantAndEquipmentMember
494 Plant and equipment [member] Member kzia:PlantAndEquipmentMember
495 Classes of intangible assets other than goodwill [axis] Axis ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis
496 Intangible assets other than goodwill [member] Member ifrs-full:IntangibleAssetsOtherThanGoodwillMember
497 Patents and intellectual property [member] Member ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember
498 Software [member] Member ifrs-full:ComputerSoftwareMember
499 Licensing agreement for GDC-0084 [member] Member kzia:LicenseAgreementMember
500 Range [axis] Axis ifrs-full:RangeAxis
501 Ranges [member] Member ifrs-full:RangesMember
502 Bottom of range [member] Member ifrs-full:BottomOfRangeMember
503 Top of range [member] Member ifrs-full:TopOfRangeMember
504 Temporary difference, unused tax losses and unused tax credits [axis] Axis ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis
505 Temporary difference, unused tax losses and unused tax credits [member] Member ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember
506 Research and development tax incentive program [member] Member kzia:ResearchAndDevelopmentTaxIncentiveProgramMember
507 Disclosure of summary of significant accounting policies [line items] LineItems kzia:DisclosureOfSummaryOfSignificantAccountingPoliciesLineItems
508 Consolidated loss after income tax Concept (Monetary) For Period Credit ifrs-full:ProfitLoss
509 Net current asset position Concept (Monetary) As Of Debit ifrs-full:CurrentAssetsLiabilities
510 Net cash outflows from operating activities Concept (Monetary) For Period ifrs-full:CashFlowsFromUsedInOperatingActivities
511 Consolidated cash in hand and at bank Concept (Monetary) As Of Debit ifrs-full:CashAndCashEquivalents
512 Current assets Concept (Monetary) As Of Debit ifrs-full:CurrentAssets
513 Excess value of share Concept (Monetary) For Period Credit kzia:ExcessValueOfShares
514 Additional tax deduction percentage Concept (Percent) For Period kzia:AdditionalTaxDeductionPercentage
515 Earning income Concept (Monetary) For Period Credit kzia:InterestIncomeLoss
516 Trade receivables settlement period Concept (xbrli:durationItemType) For Period kzia:TradeReceivablesPaymentPeriod
517 Overdue period where trade receivables may be impaired Concept (xbrli:durationItemType) For Period kzia:OverduePeriodWhereTradeReceivablesMayBeImpaired
518 Estimated useful life of assets Concept (Text/String) For Period ifrs-full:UsefulLivesOrDepreciationRatesPropertyPlantAndEquipment
519 Useful lives of intangible assets Concept (Text/String) For Period ifrs-full:UsefulLivesOrAmortisationRatesIntangibleAssetsOtherThanGoodwill
520 Remaining useful life,licensing agreement Concept (Text/String) For Period kzia:IntangibleAssetsWithIndefiniteRemainingUsefulLife
521 Trade and other payables payment period Concept (xbrli:durationItemType) For Period kzia:TradePayablesSettlementPeriod
522 1075 - Disclosure - Operating segments - Additional Information (Detail) Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/DisclosureOperatingSegmentsAdditionalInformation
523 Implied Table Table

*

*

 implied:Table
524 Disclosure of operating segments [abstract] Abstract ifrs-full:DisclosureOfOperatingSegmentsAbstract
525 Number of operating segments Concept (Integer) For Period kzia:NumberOfOperatingSegments1
526 Number of major customers Concept (Integer) For Period kzia:NumberOfMajorCustomers
527 1076 - Disclosure - Revenue - Summary of revenue (Detail) Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/DisclosureRevenueSummaryOfRevenue
528 Implied Table Table

*

*

 implied:Table
529 Revenue [abstract] Abstract ifrs-full:RevenueAbstract
530 From continuing operations Abstract kzia:ContinuingOperationsAbstract
531 Bank interest Concept (Monetary) For Period Credit ifrs-full:RevenueFromInterest
532 Sales revenue Concept (Monetary) For Period Credit ifrs-full:RevenueFromSaleOfGoods
533 Revenue from continuing operations Concept (Monetary) For Period Credit ifrs-full:Revenue
534 1077 - Disclosure - Other income - Summary of other income (Detail) Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/DisclosureOtherIncomeSummaryOfOtherIncome
535 Implied Table Table

*

*

 implied:Table
536 Material income and expense [abstract] Abstract ifrs-full:MaterialIncomeAndExpenseAbstract
537 Net foreign exchange gain Concept (Monetary) For Period Credit ifrs-full:NetForeignExchangeGain
538 Payroll tax rebate Concept (Monetary) For Period Credit kzia:TaxRebatesOnPayroll
539 Subsidies and grants Concept (Monetary) For Period Credit kzia:SubsidiesAndGrants
540 Gain on legal settlement Concept (Monetary) For Period Credit kzia:GainOnLegalSettlement
541 Reimbursement of expenses Concept (Monetary) For Period Credit kzia:ReimbursementOfExpenses
542 Research and development rebate Concept (Monetary) For Period Credit kzia:RebateIncomeOnResearchAndDevelopment
543 Gain on revaluation of contingent consideration Concept (Monetary) For Period Credit kzia:GainLossOnRevaluationOfContingentConsideration
544 Other income Concept (Monetary) For Period Credit ifrs-full:OtherIncome
545 1078 - Disclosure - Expenses - Summary of expenses (Detail) Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/DisclosureExpensesSummaryOfExpenses
546 Disclosure of expenses by nature [table] Table

*

*

 kzia:DisclosureOfExpensesByNatureTable
547 Classes of property, plant and equipment [axis] Axis ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis
548 Property, plant and equipment [member] Member ifrs-full:PropertyPlantAndEquipmentMember
549 Leasehold improvements [member] Member ifrs-full:LeaseholdImprovementsMember
550 Plant and equipment [member] Member kzia:PlantAndEquipmentMember
551 Classes of intangible assets other than goodwill [axis] Axis ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis
552 Intangible assets other than goodwill [member] Member ifrs-full:IntangibleAssetsOtherThanGoodwillMember
553 Patents and intellectual property [member] Member ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember
554 Software [member] Member ifrs-full:ComputerSoftwareMember
555 GDC licensing agreement [member] Member ifrs-full:LicencesMember
556 Disclosure of expenses by nature [line items] LineItems kzia:DisclosureOfExpensesByNatureLineItems
557 Loss before income tax includes the following specific expenses: Abstract ifrs-full:ProfitLossAbstract
558 Depreciation Concept (Monetary) For Period ifrs-full:DepreciationPropertyPlantAndEquipment
559 Amortisation Concept (Monetary) For Period ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
560 Total depreciation and amortisation Concept (Monetary) For Period Debit ifrs-full:DepreciationAndAmortisationExpense
561 Impairment of property, plant and equipment Concept (Monetary) For Period ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment
562 Interest and finance charges paid/payable Concept (Monetary) For Period Debit ifrs-full:InterestExpense
563 Minimum lease payments Concept (Monetary) For Period Debit ifrs-full:MinimumOperatingLeasePayments
564 Defined contribution superannuation expense Concept (Monetary) For Period Debit ifrs-full:PostemploymentBenefitExpenseDefinedContributionPlans
565 Employee benefits expense excluding superannuation Concept (Monetary) For Period Debit ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans
566 Revaluation of contingent consideration Concept (Monetary) For Period Debit kzia:RevaluationOfContingentConsideratiOnExpense
567 1079 - Disclosure - Income tax benefit - Summary of Income tax benefit (Detail) Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/DisclosureIncomeTaxBenefitSummaryOfIncomeTaxBenefit
568 Disclosure of income tax benefits [Table] Table

*

*

 kzia:DisclosureOfIncomeTaxBenefitsTable
569 Geographical areas [axis] Axis ifrs-full:GeographicalAreasAxis
570 Geographical areas [member] Member ifrs-full:GeographicalAreasMember
571 Australia [member] Member country:AU
572 US [member] Member country:US
573 Disclosure Of Income Tax Benefit [Line Items] LineItems kzia:DisclosureOfIncomeTaxBenefitLineItems
574 Numerical reconciliation of income tax benefit and tax at the statutory rate Abstract ifrs-full:ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract
575 Loss before income tax benefit Concept (Monetary) For Period Credit ifrs-full:ProfitLossBeforeTax
576 Tax at the statutory tax rate of 27.5% (2017: 27.5%, 2016: 30%) Concept (Monetary) For Period Debit ifrs-full:TaxExpenseIncomeAtApplicableTaxRate
577 Tax effect amounts which are not deductible/(taxable) in calculating taxable income: Abstract kzia:TaxEffectAmountsWhichAreNotDeductibleTaxableInCalculatingTaxableIncomeAbstract
578 Impact of foreign tax rate differential Concept (Monetary) For Period Debit ifrs-full:TaxEffectOfForeignTaxRates
579 Research and Development claim Concept (Monetary) For Period Debit kzia:TaxEffectOfExpenseResearchAndDevelopmentClaim
580 Capitalised expenses Concept (Monetary) For Period Debit kzia:TaxEffectOfCapitalisedExpenses
581 Employee option plan Concept (Monetary) For Period Debit kzia:TaxEffectOfExpenseEmployeeOptionPlan
582 Gain/loss on revaluation of contingent consideration Concept (Monetary) For Period Debit kzia:TaxEffectOfGainLossOnRevaluationOfContingentConsiderationPayable
583 Other non-deductible expenses Concept (Monetary) For Period Debit kzia:TaxEffectOfOtherNondeductibleExpenses
584 Tax effect amounts which are not deductible/(taxable) in calculating taxable income Concept (Monetary) For Period Debit kzia:TaxEffectOfExpenseNotDeductibleAndTaxableInDeterminingTaxableProfitTaxLoss
585 Prior year tax losses not recognised now recouped Concept (Monetary) For Period Debit kzia:TaxEffectOfPriorYearTaxLossesNotRecognisedNowRecouped
586 Tax losses and timing differences not recognised Concept (Monetary) For Period Debit kzia:TaxEffectOfTaxLossesAndTimingDifferencesNotRecognised
587 Income tax benefit Concept (Monetary) For Period Debit ifrs-full:IncomeTaxExpenseContinuingOperations
588 Tax losses not recognised Abstract kzia:TaxLossesNotRecognisedAbstract
589 Unused tax losses for which no deferred tax asset has been recognised Concept (Monetary) As Of ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised
590 Potential tax benefit Concept (Monetary) For Period Debit ifrs-full:DeferredTaxExpenseIncomeRelatingToTaxRateChangesOrImpositionOfNewTaxes
591 1080 - Disclosure - Income tax benefit - Summary of Income tax benefit (Parenthetical) (Detail) Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/DisclosureIncomeTaxBenefitSummaryOfIncomeTaxBenefitParenthetical
592 Disclosure of income tax benefits [Table] Table

*

*

 kzia:DisclosureOfIncomeTaxBenefitsTable
593 Geographical areas [axis] Axis ifrs-full:GeographicalAreasAxis
594 Geographical areas [member] Member ifrs-full:GeographicalAreasMember
595 US [member] Member country:US
596 Disclosure Of Income Tax Benefit [Line Items] LineItems kzia:DisclosureOfIncomeTaxBenefitLineItems
597 Statutory tax rate Concept (Percent) For Period ifrs-full:ApplicableTaxRate
598 1081 - Disclosure - Current assets - cash and cash equivalents - Summary of cash and cash equivalents (Detail) Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/DisclosureCurrentAssetsCashAndCashEquivalentsSummaryOfCashAndCashEquivalents
599 Implied Table Table

*

*

 implied:Table
600 Cash and cash equivalents [abstract] Abstract ifrs-full:CashAndCashEquivalentsAbstract
601 Cash at bank and on hand Concept (Monetary) As Of Debit ifrs-full:Cash
602 Short-term deposits Concept (Monetary) As Of Debit ifrs-full:ShorttermDepositsClassifiedAsCashEquivalents
603 Cash and cash equivalents Concept (Monetary) As Of Debit ifrs-full:CashAndCashEquivalents
604 1082 - Disclosure - Current assets - trade and other receivables - Summary of current assets - trade and other receivables (Detail) Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/DisclosureCurrentAssetsTradeAndOtherReceivablesSummaryOfCurrentAssetsTradeAndOtherReceivables
605 Disclosure of financial assets [table] Table

*

*

 ifrs-full:DisclosureOfFinancialAssetsTable
606 Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis] Axis ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis
607 Carrying amount [member] Member ifrs-full:CarryingAmountMember
608 Gross carrying amount [member] Member ifrs-full:GrossCarryingAmountMember
609 Provision for impairment [member] Member ifrs-full:AccumulatedImpairmentMember
610 R&D tax rebate receivable [member] Member kzia:ResearchAndDevelopmentTaxRebateReceivableMember
611 Deposits held [member] Member kzia:DepositsHeldMember
612 Disclosure of financial assets [line items] LineItems ifrs-full:DisclosureOfFinancialAssetsLineItems
613 Trade receivables Concept (Monetary) As Of Debit ifrs-full:CurrentTradeReceivables
614 Other receivables Concept (Monetary) As Of Debit ifrs-full:OtherCurrentReceivables
615 Trade and other receivables Concept (Monetary) As Of Debit ifrs-full:TradeAndOtherCurrentReceivables
616 1083 - Disclosure - Current assets - trade and other receivables - Additional Information (Detail) Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/DisclosureCurrentAssetsTradeAndOtherReceivablesAdditionalInformation
617 Implied Table Table

*

*

 implied:Table
618 Trade and other receivables [abstract] Abstract ifrs-full:TradeAndOtherReceivablesAbstract
619 Guarantee included in deposits held Concept (Monetary) As Of Debit kzia:GuaranteeDepositsAssetsCurrent
620 Recognised a loss in profit or loss in respect of impairment of receivables (excluding 'deposits held') Concept (Monetary) For Period Debit ifrs-full:ImpairmentLossRecognisedInProfitOrLossTradeReceivables
621 1084 - Disclosure - Current assets - trade and other receivables - Summary of ageing of impaired receivables (Detail) Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/DisclosureCurrentAssetsTradeAndOtherReceivablesSummaryOfAgeingOfImpairedReceivables
622 Disclosure of financial assets that are either past due or impaired [table] Table

*

*

 ifrs-full:DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable
623 Impairment of financial assets [axis] Axis ifrs-full:ImpairmentOfFinancialAssetsAxis
624 Entity's total for impairment of financial assets [member] Member ifrs-full:EntitysTotalForImpairmentOfFinancialAssetsMember
625 Impaired [member] Member ifrs-full:FinancialAssetsImpairedMember
626 Past due status [axis] Axis ifrs-full:PastDueStatusAxis
627 Past due status [member] Member ifrs-full:PastDueStatusMember
628 Over 6 months [member] Member ifrs-full:LaterThanSixMonthsMember
629 Disclosure of financial assets that are either past due or impaired [line items] LineItems ifrs-full:DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedLineItems
630 Trade receivables over 6 months overdue Concept (Monetary) As Of Debit ifrs-full:TradeAndOtherCurrentReceivables
631 1085 - Disclosure - Current assets - income tax refund due - Summary of current assets - income tax refund due (Detail) Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/DisclosureCurrentAssetsIncomeTaxRefundDueSummaryOfCurrentAssetsIncomeTaxRefundDue
632 Implied Table Table

*

*

 implied:Table
633 Statement of financial position [abstract] Abstract ifrs-full:StatementOfFinancialPositionAbstract
634 Income tax refund due Concept (Monetary) As Of Debit ifrs-full:CurrentTaxAssetsCurrent
635 1086 - Disclosure - Current assets - other - Summary of current assets - other (Detail) Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/DisclosureCurrentAssetsOtherSummaryOfCurrentAssetsOther
636 Implied Table Table

*

*

 implied:Table
637 Statement of financial position [abstract] Abstract ifrs-full:StatementOfFinancialPositionAbstract
638 Prepayments Concept (Monetary) As Of Debit ifrs-full:OtherCurrentAssets
639 1087 - Disclosure - Non-current assets - financial assets - Summary of non-current assets - financial assets (Detail) Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/DisclosureNoncurrentAssetsFinancialAssetsSummaryOfNoncurrentAssetsFinancialAssets
640 Disclosure of Non-current Financial Assets Available for Sale [Table] Table

*

*

 kzia:DisclosureOfNoncurrentFinancialAssetsAvailableForSaleTable
641 Categories of financial assets [axis] Axis ifrs-full:CategoriesOfFinancialAssetsAxis
642 Financial assets, category [member] Member ifrs-full:FinancialAssetsCategoryMember
643 Listed ordinary shares - available-for-sale [member] Member kzia:ListedOrdinarySharesMember
644 Unlisted shares and options - FVTPL [member] Member kzia:UnlistedSharesAndOptionsFairValueThroughProfitLossMember
645 Disclosure of non-current financial assets available for sale [line items] LineItems kzia:DisclosureOfNoncurrentFinancialAssetsAvailableForSaleLineItems
646 Non-current assets - available for financial assets Concept (Monetary) As Of Debit ifrs-full:NoncurrentFinancialAssetsAvailableforsale
647 1088 - Disclosure - Non-current assets - property, plant and equipment - Summary of non-current assets - property, plant and equipment (Detail) Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/DisclosureNoncurrentAssetsPropertyPlantAndEquipmentSummaryOfNoncurrentAssetsPropertyPlantAndEquipment
648 Disclosure of detailed information about property, plant and equipment [table] Table

*

*

 ifrs-full:DisclosureOfPropertyPlantAndEquipmentTable
649 Classes of property, plant and equipment [axis] Axis ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis
650 Property, plant and equipment [member] Member ifrs-full:PropertyPlantAndEquipmentMember
651 Leasehold improvements [member] Member ifrs-full:LeaseholdImprovementsMember
652 Plant and equipment [member] Member kzia:PlantAndEquipmentMember
653 Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis] Axis ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis
654 Carrying amount [member] Member ifrs-full:CarryingAmountMember
655 Gross carrying amount [member] Member ifrs-full:GrossCarryingAmountMember
656 Accumulated depreciation and amortisation [member] Member ifrs-full:AccumulatedDepreciationAndAmortisationMember
657 Disclosure of detailed information about property, plant and equipment [line items] LineItems ifrs-full:DisclosureOfPropertyPlantAndEquipmentLineItems
658 Property, plant and equipment Concept (Monetary) As Of Debit ifrs-full:PropertyPlantAndEquipment
659 1089 - Disclosure - Non-current assets - property, plant and equipment - Summary of reconciliations of property, plant and equipment (Detail) Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/DisclosureNoncurrentAssetsPropertyPlantAndEquipmentSummaryOfReconciliationsOfPropertyPlantAndEquipment
660 Disclosure of detailed information about property, plant and equipment [table] Table

*

*

 ifrs-full:DisclosureOfPropertyPlantAndEquipmentTable
661 Classes of property, plant and equipment [axis] Axis ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis
662 Property, plant and equipment [member] Member ifrs-full:PropertyPlantAndEquipmentMember
663 Leasehold improvements [member] Member ifrs-full:LeaseholdImprovementsMember
664 Plant and equipment [member] Member kzia:PlantAndEquipmentMember
665 Disclosure of detailed information about property, plant and equipment [line items] LineItems ifrs-full:DisclosureOfPropertyPlantAndEquipmentLineItems
666 Beginning balance Concept (Monetary) As Of Debit ifrs-full:PropertyPlantAndEquipment
667 Additions Concept (Monetary) For Period Debit ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
668 Disposals Concept (Monetary) For Period Credit ifrs-full:DisposalsPropertyPlantAndEquipment
669 Impairment of assets Concept (Monetary) For Period ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment
670 Depreciation expense Concept (Monetary) For Period ifrs-full:DepreciationPropertyPlantAndEquipment
671 Ending balance Concept (Monetary) As Of Debit ifrs-full:PropertyPlantAndEquipment
672 1090 - Disclosure - Non-current assets - intangibles - Summary of non-current assets - intangibles (Detail) Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/DisclosureNoncurrentAssetsIntangiblesSummaryOfNoncurrentAssetsIntangibles
673 Disclosure of detailed information about intangible assets [table] Table

*

*

 ifrs-full:DisclosureOfIntangibleAssetsTable
674 Classes of intangible assets other than goodwill [axis] Axis ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis
675 Intangible assets other than goodwill [member] Member ifrs-full:IntangibleAssetsOtherThanGoodwillMember
676 Patents and intellectual property [member] Member ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember
677 Software [member] Member ifrs-full:ComputerSoftwareMember
678 GDC licensing agreement [member] Member ifrs-full:LicencesMember
679 Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis] Axis ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis
680 Carrying amount [member] Member ifrs-full:CarryingAmountMember
681 Gross carrying amount [member] Member ifrs-full:GrossCarryingAmountMember
682 Accumulated depreciation and amortisation [member] Member ifrs-full:AccumulatedDepreciationAndAmortisationMember
683 Disclosure of detailed information about intangible assets [line items] LineItems ifrs-full:DisclosureOfIntangibleAssetsLineItems
684 Intangibles Concept (Monetary) As Of Debit ifrs-full:IntangibleAssetsOtherThanGoodwill
685 1091 - Disclosure - Non-current assets - intangibles - Summary of reconciliations of intangibles (Detail) Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/DisclosureNoncurrentAssetsIntangiblesSummaryOfReconciliationsOfIntangibles
686 Disclosure of detailed information about intangible assets [table] Table

*

*

 ifrs-full:DisclosureOfIntangibleAssetsTable
687 Classes of intangible assets other than goodwill [axis] Axis ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis
688 Intangible assets other than goodwill [member] Member ifrs-full:IntangibleAssetsOtherThanGoodwillMember
689 Software [member] Member ifrs-full:ComputerSoftwareMember
690 Patents and intellectual property [member] Member ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember
691 GDC licensing agreement [member] Member ifrs-full:LicencesMember
692 Disclosure of detailed information about intangible assets [line items] LineItems ifrs-full:DisclosureOfIntangibleAssetsLineItems
693 Beginning balance Concept (Monetary) As Of Debit ifrs-full:IntangibleAssetsOtherThanGoodwill
694 Additions Concept (Monetary) For Period Debit ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
695 Disposals Concept (Monetary) For Period Credit ifrs-full:DisposalsIntangibleAssetsOtherThanGoodwill
696 Additions through business combinations Concept (Monetary) For Period Debit ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
697 Amortisation expense Concept (Monetary) For Period ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
698 Ending balance Concept (Monetary) As Of Debit ifrs-full:IntangibleAssetsOtherThanGoodwill
699 1092 - Disclosure - Current liabilities - trade and other payables - Summary of current liabilities - trade and other payables (Detail) Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/DisclosureCurrentLiabilitiesTradeAndOtherPayablesSummaryOfCurrentLiabilitiesTradeAndOtherPayables
700 Implied Table Table

*

*

 implied:Table
701 Trade and other payables [abstract] Abstract ifrs-full:TradeAndOtherPayablesAbstract
702 Trade payables Concept (Monetary) As Of Credit ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers
703 Accrued payables Concept (Monetary) As Of Credit ifrs-full:AccrualsClassifiedAsCurrent
704 Lease incentive liability Concept (Monetary) As Of Credit ifrs-full:CurrentLeaseLiabilities
705 Total trade and other payables Concept (Monetary) As Of Credit ifrs-full:TradeAndOtherCurrentPayables
706 1093 - Disclosure - Current liabilities - provisions - Summary of current liabilities - provisions (Detail) Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/DisclosureCurrentLiabilitiesProvisionsSummaryOfCurrentLiabilitiesProvisions
707 Disclosure of Provisions [Table] Table

*

*

 kzia:DisclosureOfProvisionsTable
708 Classes of liabilities [axis] Axis ifrs-full:ClassesOfLiabilitiesAxis
709 Liabilities [member] Member ifrs-full:LiabilitiesMember
710 Employee benefits [member] Member kzia:EmployeeBenefitsMember
711 Lease make good [member] Member kzia:LeaseMakeGoodMember
712 Disclosure of provisions [line items] LineItems kzia:DisclosureOfProvisionsLineItems
713 Current liabilities - provisions Concept (Monetary) As Of Credit ifrs-full:CurrentProvisions
714 1094 - Disclosure - Current liabilities - Contingent consideration - Summary of current liabilities - Contingent consideration (Detail) Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/DisclosureCurrentLiabilitiesContingentConsiderationSummaryOfCurrentLiabilitiesContingentConsideration
715 Implied Table Table

*

*

 implied:Table
716 Disclosure of contingent liabilities [abstract] Abstract ifrs-full:DisclosureOfContingentLiabilitiesAbstract
717 Contingent consideration Concept (Monetary) As Of Credit kzia:ContingentConsiderationCurrent
718 1095 - Disclosure - Non-current liabilities - deferred tax - Summary of non-current liabilities - deferred tax (Detail) Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/DisclosureNoncurrentLiabilitiesDeferredTaxSummaryOfNoncurrentLiabilitiesDeferredTax
719 Implied Table Table

*

*

 implied:Table
720 Deferred tax assets and liabilities [abstract] Abstract ifrs-full:DeferredTaxAssetsAndLiabilitiesAbstract
721 Deferred tax liability associated with Licensing Agreement - Non-current liabilities Concept (Monetary) As Of Credit ifrs-full:DeferredTaxLiabilities
722 Amount expected to be settled within 12 months Concept (Monetary) As Of Credit kzia:DeferredTaxLiabilitiesCurrent1
723 Amount expected to be settled after more than 12 months Concept (Monetary) As Of Credit kzia:DeferredTaxLiabilitiesNonCurrent1
724 Deferred tax liability associated with Licensing Agreement - Non-current liabilities Concept (Monetary) As Of Credit ifrs-full:DeferredTaxLiabilities
725 1096 - Disclosure - Non-current liabilities - Contingent consideration - Summary of non-current liabilities - Contingent consideration (Detail) Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/DisclosureNoncurrentLiabilitiesContingentConsiderationSummaryOfNoncurrentLiabilitiesContingentConsideration
726 Implied Table Table

*

*

 implied:Table
727 Disclosure of contingent liabilities [abstract] Abstract ifrs-full:DisclosureOfContingentLiabilitiesAbstract
728 Contingent consideration Concept (Monetary) As Of Credit kzia:ContingentConsiderationNoncurrent
729 1097 - Disclosure - Equity - contributed equity - Summary of equity - contributed equity (Detail) Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/DisclosureEquityContributedEquitySummaryOfEquityContributedEquity
730 Implied Table Table

*

*

 implied:Table
731 Disclosure of classes of share capital [abstract] Abstract ifrs-full:DisclosureOfClassesOfShareCapitalAbstract
732 Ordinary shares - fully paid, shares Concept (Shares) As Of ifrs-full:NumberOfSharesIssuedAndFullyPaid
733 Ordinary shares - fully paid Concept (Monetary) As Of Credit ifrs-full:IssuedCapital
734 1098 - Disclosure - Equity - contributed equity - Summary of movements in ordinary share capital (Detail) Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/DisclosureEquityContributedEquitySummaryOfMovementsInOrdinaryShareCapital
735 Disclosure of classes of share capital [table] Table

*

*

 ifrs-full:DisclosureOfClassesOfShareCapitalTable
736 Types of share-based payment arrangements [axis] Axis ifrs-full:TypesOfSharebasedPaymentArrangementsAxis
737 Share-based payment arrangements [member] Member ifrs-full:SharebasedPaymentArrangementsMember
738 Convertible note conversion [member] Member kzia:ConvertibleNoteConversionMember
739 Share issue transaction costs [member] Member kzia:ShareIssueTransactionCostsMember
740 Business combinations [axis] Axis ifrs-full:BusinessCombinationsAxis
741 Entity's total for business combinations [member] Member ifrs-full:EntitysTotalForBusinessCombinationsMember
742 Acquisition of Glioblast Pty Ltd [member] Member kzia:AcquisitionOfGlioblastPtyLtdMember
743 Disclosure of classes of share capital [line items] LineItems ifrs-full:DisclosureOfClassesOfShareCapitalLineItems
744 Shares Concept (Shares) As Of ifrs-full:NumberOfSharesIssuedAndFullyPaid
745 Issue price Concept (Share) For Period kzia:SharesIssuedPricePerShare1
746 Contributed equity Concept (Monetary) As Of Credit ifrs-full:IssuedCapital
747 1099 - Disclosure - Equity - contributed equity - Summary of movements in ordinary share capital (Parenthetical) (Detail) Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/DisclosureEquityContributedEquitySummaryOfMovementsInOrdinaryShareCapitalParenthetical
748 Implied Table Table

*

*

 implied:Table
749 Disclosure of classes of share capital [abstract] Abstract ifrs-full:DisclosureOfClassesOfShareCapitalAbstract
750 Reverse stock split Concept (Shares) For Period kzia:ReverseStockSplit
751 Stock value Concept (Monetary) As Of Credit kzia:CommonStockValue1
752 1100 - Disclosure - Equity - contributed equity - Additional Information (Detail) Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/DisclosureEquityContributedEquityAdditionalInformation
753 Implied Table Table

*

*

 implied:Table
754 Disclosure of classes of share capital [abstract] Abstract ifrs-full:DisclosureOfClassesOfShareCapitalAbstract
755 Fully paid ordinary shares par value Concept (Share) As Of ifrs-full:ParValuePerShare
756 1101 - Disclosure - Equity - Other contributed equity - Summary of equity -Other contributed equity (Detail) Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/DisclosureEquityOtherContributedEquitySummaryOfEquityOtherContributedEquity
757 Implied Table Table

*

*

 implied:Table
758 Statement of changes in equity [abstract] Abstract ifrs-full:StatementOfChangesInEquityAbstract
759 Convertible note - Triaxial Concept (Monetary) As Of Credit ifrs-full:OtherEquityInterest
760 1102 - Disclosure - Equity - Other contributed equity - Additional Information (Detail) Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/DisclosureEquityOtherContributedEquityAdditionalInformation
761 Implied Table Table

*

*

 implied:Table
762 Statement of changes in equity [abstract] Abstract ifrs-full:StatementOfChangesInEquityAbstract
763 Number of ordinary shares issued Concept (Shares) As Of ifrs-full:NumberOfSharesIssuedAndFullyPaid
764 Number of ordinary shares available for conversion Concept (Shares) As Of kzia:NumberOfOrdinarySharesAvailableForConversion
765 Percentage of capital acquired by third party for early conversion of convertibles notes Concept (Percent) For Period kzia:PercentageOfCapitalAcquiredByThirdPartyForEarlyConversionOfConvertiblesNotes
766 Number of convertible note may be converted into ordinary shares Concept (Shares) For Period kzia:ConvertibleNoteRepresentsOrdinaryShares
767 1103 - Disclosure - Equity - dividends - Additional Information (Detail) Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/DisclosureEquityDividendsAdditionalInformation
768 Implied Table Table

*

*

 implied:Table
769 Statement of changes in equity [abstract] Abstract ifrs-full:StatementOfChangesInEquityAbstract
770 Dividends paid Concept (Monetary) For Period Debit ifrs-full:DividendsPaid
771 Franking credits available Concept (Monetary) As Of Credit kzia:FrankingCreditsAvailable
772 1104 - Disclosure - Financial instruments - Summary of foreign currency risk (Detail) Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/DisclosureFinancialInstrumentsSummaryOfForeignCurrencyRisk
773 Disclosure of detailed information about financial instruments [table] Table

*

*

 ifrs-full:DisclosureOfFinancialInstrumentsTable
774 Types of risks [axis] Axis ifrs-full:TypesOfRisksAxis
775 Risks [member] Member ifrs-full:TypesOfRisksMember
776 Foreign currency risk [member] Member ifrs-full:CurrencyRiskMember
777 Currency [Axis] Axis us-gaap:CurrencyAxis
778 All Currencies [Domain] Member currency:AllCurrenciesDomain
779 US dollars [member] Member currency:USD
780 Pound Sterling [member] Member currency:GBP
781 Disclosure of detailed information about financial instruments [line items] LineItems ifrs-full:DisclosureOfFinancialInstrumentsLineItems
782 Assets Concept (Monetary) As Of Debit ifrs-full:FinancialAssets
783 Liabilities Concept (Monetary) As Of Credit ifrs-full:FinancialLiabilities
784 1105 - Disclosure - Financial instruments - Additional Information (Detail) Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/DisclosureFinancialInstrumentsAdditionalInformation
785 Disclosure of detailed information about financial instruments [table] Table

*

*

 ifrs-full:DisclosureOfFinancialInstrumentsTable
786 Types of risks [axis] Axis ifrs-full:TypesOfRisksAxis
787 Risks [member] Member ifrs-full:TypesOfRisksMember
788 Foreign currency risk [member] Member ifrs-full:CurrencyRiskMember
789 Interest rate risk [member] Member ifrs-full:InterestRateRiskMember
790 Currency [Axis] Axis us-gaap:CurrencyAxis
791 All Currencies [Domain] Member currency:AllCurrenciesDomain
792 US dollars [member] Member currency:USD
793 Euros [member] Member currency:EUR
794 Pound Sterling [member] Member currency:GBP
795 Disclosure of detailed information about financial instruments [line items] LineItems ifrs-full:DisclosureOfFinancialInstrumentsLineItems
796 Net assets denominated in foreign currencies Concept (Monetary) As Of Debit ifrs-full:Assets
797 Hypothetical percentage change in risk Concept (Percent) As Of kzia:RiskExposureAssociatedWithInstrumentsSharingCharacteristicPercentageChangeInRisk
798 Cash and cash equivalents Concept (Monetary) As Of Debit ifrs-full:CashAndCashEquivalents
799 Favourable/adverse effect on profit before tax and equity Concept (Monetary) As Of ifrs-full:RiskExposureAssociatedWithInstrumentsSharingCharacteristic
800 1106 - Disclosure - Financial instruments - Summary of foreign currency risk sensitivity (Detail) Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/DisclosureFinancialInstrumentsSummaryOfForeignCurrencyRiskSensitivity
801 Disclosure of detailed information about financial instruments [table] Table

*

*

 ifrs-full:DisclosureOfFinancialInstrumentsTable
802 Types of risks [axis] Axis ifrs-full:TypesOfRisksAxis
803 Risks [member] Member ifrs-full:TypesOfRisksMember
804 Foreign currency risk [member] Member ifrs-full:CurrencyRiskMember
805 Range [axis] Axis ifrs-full:RangeAxis
806 Ranges [member] Member ifrs-full:RangesMember
807 Increase in market risk [member] Member kzia:IncreaseInMarketRiskMember
808 Effect of increase in market risk on profit (loss) before tax [member] Member kzia:EffectOfIncreaseInMarketRiskOnProfitLossBeforeTaxMember
809 Effect of increase in market risk on equity [member] Member kzia:EffectOfIncreaseInMarketRiskOnEquityMember
810 Decrease in market risk [member] Member kzia:DecreaseInMarketRiskMember
811 Effect of decrease in market risk on equity [member] Member kzia:EffectOfDecreaseInMarketRiskOnEquityMember
812 Effect of decrease in market risk on profit (loss) before tax [member] Member kzia:EffectOfDecreaseInMarketRiskOnProfitLossBeforeTaxMember
813 Currency [Axis] Axis us-gaap:CurrencyAxis
814 All Currencies [Domain] Member currency:AllCurrenciesDomain
815 US dollars [member] Member currency:USD
816 Pound Sterling [member] Member currency:GBP
817 Disclosure of detailed information about financial instruments [line items] LineItems ifrs-full:DisclosureOfFinancialInstrumentsLineItems
818 % change Concept (Percent) As Of kzia:RiskExposureAssociatedWithInstrumentsSharingCharacteristicPercentageChangeInRisk
819 Effect on profit before tax/equity Concept (Monetary) As Of ifrs-full:RiskExposureAssociatedWithInstrumentsSharingCharacteristic
820 1107 - Disclosure - Financial instruments - Summary of variable interest rate balances (Detail) Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/DisclosureFinancialInstrumentsSummaryOfVariableInterestRateBalances
821 Disclosure of financial instruments by type of interest rate [table] Table

*

*

 ifrs-full:DisclosureOfFinancialInstrumentsByTypeOfInterestRateTable
822 Types of risks [axis] Axis ifrs-full:TypesOfRisksAxis
823 Risks [member] Member ifrs-full:TypesOfRisksMember
824 Interest rate risk [member] Member ifrs-full:InterestRateRiskMember
825 Types of interest rates [axis] Axis ifrs-full:TypesOfInterestRatesAxis
826 Interest rate types [member] Member ifrs-full:InterestRateTypesMember
827 Variable interest rate [member] Member ifrs-full:FloatingInterestRateMember
828 Range [axis] Axis ifrs-full:RangeAxis
829 Ranges [member] Member ifrs-full:RangesMember
830 Weighted average [member] Member ifrs-full:WeightedAverageMember
831 Classes of financial instruments [axis] Axis ifrs-full:ClassesOfFinancialInstrumentsAxis
832 Financial instruments, class [member] Member ifrs-full:ClassesOfFinancialInstrumentsMember
833 Cash at bank and in hand [member] Member kzia:CashAtBankAndInHandMember
834 Short term deposits [member] Member kzia:ShortTermDepositsMember
835 Disclosure of financial instruments by type of interest rate [line items] LineItems ifrs-full:DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems
836 Interest rate Concept (Percent) For Period kzia:InterestRate
837 Cash at bank and in hand Concept (Monetary) As Of Debit ifrs-full:Cash
838 Short term deposits Concept (Monetary) As Of Debit ifrs-full:ShorttermDepositsClassifiedAsCashEquivalents
839 Net exposure to cash flow interest rate risk Concept (Monetary) As Of Debit ifrs-full:FinancialAssets
840 1108 - Disclosure - Financial instruments - Summary of remaining contractual maturities of financial instrument liabilities (Detail) Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/DisclosureFinancialInstrumentsSummaryOfRemainingContractualMaturitiesOfFinancialInstrumentLiabilities
841 Disclosure of maturity analysis for non-derivative financial liabilities [table] Table

*

*

 ifrs-full:DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesTable
842 Maturity [axis] Axis ifrs-full:MaturityAxis
843 Aggregated time bands [member] Member ifrs-full:AggregatedTimeBandsMember
844 1 year or less [member] Member ifrs-full:NotLaterThanOneYearMember
845 Between 2 and 5 years [member] Member ifrs-full:LaterThanTwoYearsAndNotLaterThanFiveYearsMember
846 Over 5 years [member] Member ifrs-full:LaterThanFiveYearsMember
847 Classes of financial liabilities [axis] Axis ifrs-full:ClassesOfFinancialLiabilitiesAxis
848 Financial liabilities, class [member] Member ifrs-full:FinancialLiabilitiesMember
849 Trade payables [member] Member kzia:TradePayablesMember
850 Accrued payables [member] Member kzia:AccruedPayablesMember
851 Contingent consideration [member] Member kzia:ContingentConsiderationMember
852 Disclosure of maturity analysis for non-derivative financial liabilities [line items] LineItems ifrs-full:DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesLineItems
853 Weighted average interest rate Concept (Percent) As Of kzia:NonDerivativeFinancialLiabilitiesWeightedAverageInterestRate
854 Trade payables Concept (Monetary) As Of Credit kzia:TradePayablesUndiscountedCashFlows
855 Accrued payables Concept (Monetary) As Of Credit kzia:AccruedPayablesUndiscountedCashFlows
856 Contingent consideration Concept (Monetary) As Of Credit kzia:ContingentConsiderationUndiscountedCashFlows
857 Total non-derivatives Concept (Monetary) As Of Credit ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows
858 1109 - Disclosure - Fair value measurement - Summary of assets and liabilities, measured or disclosed at fair value (Detail) Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/DisclosureFairValueMeasurementSummaryOfAssetsAndLiabilitiesMeasuredOrDisclosedAtFairValue
859 Disclosure of fair value measurement of assets [table] Table

*

*

 ifrs-full:DisclosureOfFairValueMeasurementOfAssetsTable
860 Measurement [axis] Axis ifrs-full:MeasurementAxis
861 Aggregated measurement [member] Member ifrs-full:AggregatedMeasurementMember
862 At fair value [member] Member ifrs-full:AtFairValueMember
863 Levels of fair value hierarchy [axis] Axis ifrs-full:LevelsOfFairValueHierarchyAxis
864 All levels of fair value hierarchy [member] Member ifrs-full:AllLevelsOfFairValueHierarchyMember
865 Level 1 [member] Member ifrs-full:Level1OfFairValueHierarchyMember
866 Level 3 [member] Member ifrs-full:Level3OfFairValueHierarchyMember
867 Categories of financial assets [axis] Axis ifrs-full:CategoriesOfFinancialAssetsAxis
868 Financial assets, category [member] Member ifrs-full:FinancialAssetsCategoryMember
869 Listed ordinary shares - available-for-sale [member] Member kzia:ListedOrdinarySharesMember
870 Unlisted options [member] Member kzia:UnlistedOptionsMember
871 Disclosure of fair value measurement of assets [line items] LineItems ifrs-full:DisclosureOfFairValueMeasurementOfAssetsLineItems
872 Assets Concept (Monetary) As Of Debit ifrs-full:NoncurrentFinancialAssetsAvailableforsale
873 Total assets Concept (Monetary) As Of Debit ifrs-full:Assets
874 Contingent consideration Concept (Monetary) As Of Credit kzia:ContingentConsiderationNoncurrent
875 Total liabilities Concept (Monetary) As Of Credit ifrs-full:Liabilities
876 1110 - Disclosure - Fair value measurement - Additional Information (Detail) Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/DisclosureFairValueMeasurementAdditionalInformation
877 Implied Table Table

*

*

 implied:Table
878 Disclosure of fair value measurement of assets [abstract] Abstract ifrs-full:DisclosureOfFairValueMeasurementOfAssetsAbstract
879 Transfers between Level 1 and Level 2 Concept (Monetary) For Period ifrs-full:TransfersOutOfLevel1IntoLevel2OfFairValueHierarchyAssets
880 Transfers between Level 2 and Level 1 Concept (Monetary) For Period ifrs-full:TransfersOutOfLevel2IntoLevel1OfFairValueHierarchyAssets
881 Transfers into Level 3 Concept (Monetary) For Period Debit ifrs-full:TransfersIntoLevel3OfFairValueHierarchyAssets
882 Transfers out of Level 3 Concept (Monetary) For Period Credit ifrs-full:TransfersOutOfLevel3OfFairValueHierarchyAssets
883 1111 - Disclosure - Key management personnel disclosures - Summary of compensation made to directors and other members of key management personnel (Detail) Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/DisclosureKeyManagementPersonnelDisclosuresSummaryOfCompensationMadeToDirectorsAndOtherMembersOfKeyManagementPersonnel
884 Implied Table Table

*

*

 implied:Table
885 Related party transactions [abstract] Abstract ifrs-full:RelatedPartyTransactionsAbstract
886 Short-term employee benefits Concept (Monetary) For Period Debit ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits
887 Post-employment benefits Concept (Monetary) For Period Debit ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits
888 Long-term benefits Concept (Monetary) For Period Debit ifrs-full:KeyManagementPersonnelCompensationOtherLongtermBenefits
889 Termination benefits Concept (Monetary) For Period Debit ifrs-full:KeyManagementPersonnelCompensationTerminationBenefits
890 Share-based payments Concept (Monetary) For Period Debit ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment
891 Key management personnel compensation Concept (Monetary) For Period Debit ifrs-full:KeyManagementPersonnelCompensation
892 1112 - Disclosure - Remuneration of auditors - Summary of remuneration of auditors (Detail) Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/DisclosureRemunerationOfAuditorsSummaryOfRemunerationOfAuditors
893 Implied Table Table

*

*

 implied:Table
894 Auditor's remuneration [abstract] Abstract ifrs-full:AuditorsRemunerationAbstract
895 Audit or review of the financial statements Concept (Monetary) For Period Debit ifrs-full:AuditorsRemunerationForAuditServices
896 F3 consent Concept (Monetary) For Period Debit ifrs-full:AuditorsRemunerationForOtherServices
897 Tax compliance services Concept (Monetary) For Period Debit ifrs-full:AuditorsRemunerationForTaxServices
898 Auditors remuneration Concept (Monetary) For Period Debit ifrs-full:AuditorsRemuneration
899 1113 - Disclosure - Contingent liabilities - Additional Information (Detail) Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/DisclosureContingentLiabilitiesAdditionalInformation
900 Implied Table Table

*

*

 implied:Table
901 Disclosure of contingent liabilities [abstract] Abstract ifrs-full:DisclosureOfContingentLiabilitiesAbstract
902 Guarantee provided to confirm its commitment to the ongoing enforcement process Concept (Monetary) As Of Debit kzia:GuaranteeDepositsAssetsCurrent
903 1114 - Disclosure - Commitments - Summary of lease commitments - operating (Detail) Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/DisclosureCommitmentsSummaryOfLeaseCommitmentsOperating
904 Disclosure of finance lease and operating lease by lessee [table] Table

*

*

 ifrs-full:DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeTable
905 Maturity [axis] Axis ifrs-full:MaturityAxis
906 Aggregated time bands [member] Member ifrs-full:AggregatedTimeBandsMember
907 1 year or less [member] Member ifrs-full:NotLaterThanOneYearMember
908 One to five years [member] Member ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember
909 Disclosure of finance lease and operating lease by lessee [line items] LineItems ifrs-full:DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeLineItems
910 Lease commitments - operating Concept (Monetary) As Of Credit ifrs-full:MinimumLeasePaymentsPayableUnderNoncancellableOperatingLease
911 1115 - Disclosure - Commitments - Additional Information (Detail) Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/DisclosureCommitmentsAdditionalInformation
912 Implied Table Table

*

*

 implied:Table
913 Disclosure of finance lease and operating lease by lessee [abstract] Abstract ifrs-full:DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeAbstract
914 Leases of premises and plant and equipment under non-cancellable operating leases expiration period Concept (xbrli:durationItemType) For Period kzia:OperatingLeaseCommitmentsExpiryTerm
915 1116 - Disclosure - Related party transactions - Summary of transactions occurred with related parties (Detail) Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/DisclosureRelatedPartyTransactionsSummaryOfTransactionsOccurredWithRelatedParties
916 Disclosure of transactions between related parties [table] Table

*

*

 ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesTable
917 Categories of related parties [axis] Axis ifrs-full:CategoriesOfRelatedPartiesAxis
918 Entity's total for related parties [member] Member ifrs-full:EntitysTotalForRelatedPartiesMember
919 Watkins Coffey Martin [member] Member kzia:WatkinsCoffeyMartinMember
920 Prue Kelly [member] Member kzia:PrueKellyMember
921 Iain Ross [member] Member kzia:IainRossMember
922 Kumara Inc [member] Member kzia:KumaraIncMember
923 John O'Connor [member] Member kzia:JohnOConnorMember
924 Disclosure of transactions between related parties [line items] LineItems ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesLineItems
925 Accounting fees paid Concept (Monetary) For Period Debit ifrs-full:OtherFeeAndCommissionExpense
926 Salary paid Concept (Monetary) For Period Debit ifrs-full:WagesAndSalaries
927 Director's fees, Consultancy fees for executive duties Concept (Monetary) For Period Debit ifrs-full:ProfessionalFeesExpense
928 1117 - Disclosure - Related party transactions - Additional Information (Detail) Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformation
929 Implied Table Table

*

*

 implied:Table
930 Related party transactions [abstract] Abstract ifrs-full:RelatedPartyTransactionsAbstract
931 Other transactions with related parties Concept (Monetary) For Period Credit kzia:OtherTransactionsWithRelatedParty
932 Trade receivables from related parties Concept (Monetary) As Of Debit ifrs-full:AmountsReceivableRelatedPartyTransactions
933 Trade payables to related parties Concept (Monetary) As Of Credit ifrs-full:AmountsPayableRelatedPartyTransactions
934 Loan to related parties Concept (Monetary) As Of Credit ifrs-full:OutstandingCommitmentsMadeOnBehalfOfEntityRelatedPartyTransactions
935 Loan from related parties Concept (Monetary) As Of Credit ifrs-full:OutstandingCommitmentsMadeByEntityRelatedPartyTransactions
936 1118 - Disclosure - Parent entity information - Statement of profit or loss and other comprehensive income (Detail) Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/DisclosureParentEntityInformationStatementOfProfitOrLossAndOtherComprehensiveIncome
937 Disclosure Of Parent Entity Information [Table] Table

*

*

 kzia:DisclosureOfParentEntityInformationTable
938 Categories of related parties [axis] Axis ifrs-full:CategoriesOfRelatedPartiesAxis
939 Entity's total for related parties [member] Member ifrs-full:EntitysTotalForRelatedPartiesMember
940 Parent [member] Member ifrs-full:ParentMember
941 Disclosure of parent entity information [line items] LineItems kzia:DisclosureOfParentEntityInformationLineItems
942 Loss after income tax Concept (Monetary) For Period Credit ifrs-full:ProfitLoss
943 Total comprehensive income Concept (Monetary) For Period Credit ifrs-full:ComprehensiveIncome
944 1119 - Disclosure - Parent entity information - Statement of financial position (Detail) Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/DisclosureParentEntityInformationStatementOfFinancialPosition
945 Disclosure Of Parent Entity Information [Table] Table

*

*

 kzia:DisclosureOfParentEntityInformationTable
946 Categories of related parties [axis] Axis ifrs-full:CategoriesOfRelatedPartiesAxis
947 Entity's total for related parties [member] Member ifrs-full:EntitysTotalForRelatedPartiesMember
948 Parent [member] Member ifrs-full:ParentMember
949 Disclosure of parent entity information [line items] LineItems kzia:DisclosureOfParentEntityInformationLineItems
950 Total current assets Concept (Monetary) As Of Debit ifrs-full:CurrentAssets
951 Total assets Concept (Monetary) As Of Debit ifrs-full:Assets
952 Total current liabilities Concept (Monetary) As Of Credit ifrs-full:CurrentLiabilities
953 Total liabilities Concept (Monetary) As Of Credit ifrs-full:Liabilities
954 Equity Abstract ifrs-full:EquityAbstract
955 Contributed equity Concept (Monetary) As Of Credit ifrs-full:IssuedCapital
956 Other contributed equity Concept (Monetary) As Of Credit ifrs-full:OtherEquityInterest
957 Reserves Concept (Monetary) As Of Credit ifrs-full:OtherReserves
958 Accumulated losses Concept (Monetary) As Of Credit ifrs-full:RetainedEarnings
959 Total equity Concept (Monetary) As Of Credit ifrs-full:Equity
960 1120 - Disclosure - Parent entity information - Additional Information (Detail) Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/DisclosureParentEntityInformationAdditionalInformation
961 Disclosure Of Parent Entity Information [Table] Table

*

*

 kzia:DisclosureOfParentEntityInformationTable
962 Categories of related parties [axis] Axis ifrs-full:CategoriesOfRelatedPartiesAxis
963 Entity's total for related parties [member] Member ifrs-full:EntitysTotalForRelatedPartiesMember
964 Parent [member] Member ifrs-full:ParentMember
965 Disclosure of parent entity information [line items] LineItems kzia:DisclosureOfParentEntityInformationLineItems
966 Share based payments reserve Concept (Monetary) As Of Credit ifrs-full:ReserveOfSharebasedPayments
967 Available for sale reserve Concept (Monetary) As Of Credit ifrs-full:ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssets
968 Contingent liabilities Concept (Monetary) As Of Credit kzia:ContingentLiabilities
969 Capital commitments for property, plant and equipment Concept (Monetary) As Of Credit kzia:CapitalCommitmentsPropertyPlantAndEquipment
970 1121 - Disclosure - Business combinations - Additional Information (Detail) Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/DisclosureBusinessCombinationsAdditionalInformation
971 Disclosure of detailed information about business combination [table] Table

*

*

 ifrs-full:DisclosureOfBusinessCombinationsTable
972 Business combinations [axis] Axis ifrs-full:BusinessCombinationsAxis
973 Entity's total for business combinations [member] Member ifrs-full:EntitysTotalForBusinessCombinationsMember
974 Glioblast Pty Ltd [member] Member kzia:GlioblastPtyLtdMember
975 Genentech agreement [member] Member kzia:GenentechAgreementMember
976 Disclosure of detailed information about business combination [line items] LineItems ifrs-full:DisclosureOfBusinessCombinationsLineItems
977 Percentage acquired of the issued shares Concept (Percent) As Of ifrs-full:PercentageOfVotingEquityInterestsAcquired
978 Acquisition-related costs Concept (Monetary) For Period Debit ifrs-full:AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination
979 Goodwill arising from business combination Concept (Monetary) As Of Debit ifrs-full:Goodwill
980 Revenue of acquiree from the date of acquisition Concept (Monetary) For Period Credit ifrs-full:RevenueOfAcquiree
981 Profit of acquiree from the date of acquisition Concept (Monetary) For Period Credit ifrs-full:ProfitLossOfAcquiree
982 Group's revenue had the acquisition occurred on 1 July 2016 Concept (Monetary) For Period Credit ifrs-full:RevenueOfCombinedEntity
983 Number of contingent milestone payments Concept (Integer) For Period kzia:NumberOfContingentMilestonePayments
984 Milestone payment discount rate Concept (Percent) For Period kzia:MilestonePaymentDiscountRate
985 1122 - Disclosure - Business combinations - Summary of details of acquisition (Detail) Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/DisclosureBusinessCombinationsSummaryOfDetailsOfAcquisition
986 Disclosure of detailed information about business combination [table] Table

*

*

 ifrs-full:DisclosureOfBusinessCombinationsTable
987 Business combinations [axis] Axis ifrs-full:BusinessCombinationsAxis
988 Entity's total for business combinations [member] Member ifrs-full:EntitysTotalForBusinessCombinationsMember
989 Glioblast Pty Ltd [member] Member kzia:GlioblastPtyLtdMember
990 Disclosure of detailed information about business combination [line items] LineItems ifrs-full:DisclosureOfBusinessCombinationsLineItems
991 Intellectual property Concept (Monetary) As Of Debit ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate
992 Deferred tax liability Concept (Monetary) As Of Credit ifrs-full:DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate
993 Net assets acquired Concept (Monetary) As Of Debit ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed
994 Goodwill Concept (Monetary) As Of Debit ifrs-full:Goodwill
995 Acquisition-date fair value of the total consideration transferred Concept (Monetary) As Of Credit ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred
996 Cash paid or payable to vendor Concept (Monetary) As Of Credit ifrs-full:CashTransferred
997 Less: shares issued by company as part of consideration Concept (Monetary) As Of Credit ifrs-full:EquityInterestsOfAcquirer
998 Contingent consideration Concept (Monetary) As Of Debit ifrs-full:ContingentConsiderationArrangementsAndIndemnificationAssetsRecognisedAsOfAcquisitionDate
999 Total Concept (Monetary) As Of Credit ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred
1000 1123 - Disclosure - Business combinations - Summary of range of outcomes of contingent consideration (Detail) Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/DisclosureBusinessCombinationsSummaryOfRangeOfOutcomesOfContingentConsideration
1001 Disclosure of transactions recognised separately from acquisition of assets and assumption of liabilities in business combination [table] Table

*

*

 ifrs-full:DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationTable
1002 Transactions recognised separately from acquisition of assets and assumption of liabilities in business combination [axis] Axis ifrs-full:TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis
1003 Transactions recognised separately from acquisition of assets and assumption of liabilities in business combination [member] Member ifrs-full:TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationMember
1004 Milestone 1 [member] Member kzia:MilestonesOneMember
1005 Milestone 2 [member] Member kzia:MilestonesTwoMember
1006 Milestone 3 [member] Member kzia:MilestonesThreeMember
1007 Milestone 4 [member] Member kzia:MilestonesFourMember
1008 Milestone 5 [member] Member kzia:MilestonesFiveMember
1009 Range [axis] Axis ifrs-full:RangeAxis
1010 Ranges [member] Member ifrs-full:RangesMember
1011 Bottom of range [member] Member ifrs-full:BottomOfRangeMember
1012 Top of range [member] Member ifrs-full:TopOfRangeMember
1013 Disclosure of transactions recognised separately from acquisition of assets and assumption of liabilities in business combination [line items] LineItems ifrs-full:DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationLineItems
1014 Contingent consideration Concept (Monetary) As Of Debit ifrs-full:ContingentConsiderationArrangementsAndIndemnificationAssetsRecognisedAsOfAcquisitionDate
1015 1124 - Disclosure - Interests in subsidiaries - Summary of interest in subsidiaries (Detail) Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/DisclosureInterestsInSubsidiariesSummaryOfInterestInSubsidiaries
1016 Disclosure of subsidiaries [table] Table

*

*

 ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesTable
1017 Subsidiaries [axis] Axis ifrs-full:SignificantInvestmentsInSubsidiariesAxis
1018 Entity's total for subsidiaries [member] Member ifrs-full:EntitysTotalForSubsidiariesMember
1019 Kazia Laboratories Pty Ltd [member] Member kzia:KaziaLaboratoriesPtyLtdMember
1020 Kazia Research Pty Ltd [member] Member kzia:KaziaResearchPtyLtdMember
1021 Kazia Therapeutics Inc [member] Member kzia:KaziaTherapeuticsIncMember
1022 Glioblast Pty Ltd [member] Member kzia:GlioblastPtyLtdMember
1023 Disclosure of subsidiaries [line items] LineItems ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesLineItems
1024 Principal place of business Concept (Text/String) For Period ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary
1025 Country of incorporation Concept (Text/String) For Period ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary
1026 Ownership interest Concept (Percent) For Period ifrs-full:ProportionOfOwnershipInterestInSubsidiary
1027 1125 - Disclosure - Deed of cross guarantee - Additional Information (Detail) Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/DisclosureDeedOfCrossGuaranteeAdditionalInformation
1028 Disclosure of deed of cross guarantee [table] Table

*

*

 kzia:DisclosureOfDeedOfCrossGuaranteeTable
1029 Range [axis] Axis ifrs-full:RangeAxis
1030 Ranges [member] Member ifrs-full:RangesMember
1031 Top of range [member] Member ifrs-full:TopOfRangeMember
1032 Disclosure of deed of cross guarantee [line items] LineItems kzia:DisclosureOfDeedOfCrossGuaranteeLineItems
1033 General and Administrative expenses, difference amount of closed group to that off consolidated entity Concept (Monetary) For Period Debit kzia:GeneralAndAdministrativeExpensesDifferenceAmountOfClosedGroupAndConsolidatedEntity
1034 Income (loss) before tax, difference amount of closed group to that off consolidated entity Concept (Monetary) For Period Credit kzia:IncomeLossBeforeTaxDifferenceAmountOfClosedGroupAndConsolidatedEntity
1035 Income (loss) after tax, difference amount of closed group to that off consolidated entity Concept (Monetary) For Period Credit kzia:IncomeLossAfterTaxDifferenceAmountOfClosedGroupAndConsolidatedEntity
1036 Assets of closed group differ from consolidated entity Concept (Monetary) For Period Debit kzia:AssetsDifferenceAmountOfClosedGroupFromConsolidatedEntity
1037 Liabilities of closed group differ from consolidated entity Concept (Monetary) For Period Credit kzia:LiabilitiesDifferenceAmountOfClosedGroupFromConsolidatedEntity
1038 Net assets of closed group differ from consolidated entity Concept (Monetary) For Period Debit kzia:NetAssetsOfClosedGroupDifferFromConsolidatedEntity
1039 1126 - Disclosure - Events after the reporting period - Additional Information (Detail) Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/DisclosureEventsAfterTheReportingPeriodAdditionalInformation
1040 Disclosure of non-adjusting events after reporting period [table] Table

*

*

 ifrs-full:DisclosureOfNonadjustingEventsAfterReportingPeriodTable
1041 Non-adjusting events after reporting period [axis] Axis ifrs-full:NonadjustingEventsAfterReportingPeriodAxis
1042 Non-adjusting events after reporting period [member] Member ifrs-full:NonadjustingEventsMember
1043 Anti tropomyosin program [member] Member kzia:AntiTropomyosinProgramMember
1044 Subsequent Event [Member] Member us-gaap:SubsequentEventMember
1045 Types of share-based payment arrangements [axis] Axis ifrs-full:TypesOfSharebasedPaymentArrangementsAxis
1046 Share-based payment arrangements [member] Member ifrs-full:SharebasedPaymentArrangementsMember
1047 Share purchase plan [Member] Member kzia:SharePurchasePlanMember
1048 Legal Entity [Axis] Axis dei:LegalEntityAxis
1049 Entity [Domain] Member dei:EntityDomain
1050 TroBio Therapeutics Proprietary Limited [Member] Member kzia:TrobioTherapeuticsProprietaryLimitedMember
1051 Range [axis] Axis ifrs-full:RangeAxis
1052 Ranges [member] Member ifrs-full:RangesMember
1053 Top of range [member] Member ifrs-full:TopOfRangeMember
1054 Disclosure of non-adjusting events after reporting period [line items] LineItems ifrs-full:DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems
1055 Equity interest, percentage Concept (Percent) For Period ifrs-full:ProportionOfOwnershipInterestInAssociate
1056 Share placement amount Concept (Monetary) For Period Credit kzia:SharePlacementAmount
1057 Share placement eligibility ownership capacity amount Concept (Monetary) For Period Credit kzia:SharePlacementEligibilityOwnershipCapacityAmount
1058 Share purchase plan maturity date Concept (Date) For Period kzia:SharePurchasePlanMaturityDate
1059 1127 - Disclosure - Earnings per share - Summary of earnings per share (Detail) Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/DisclosureEarningsPerShareSummaryOfEarningsPerShare
1060 Implied Table Table

*

*

 implied:Table
1061 Earnings per share [abstract] Abstract ifrs-full:EarningsPerShareAbstract
1062 Loss after income tax attributable to the owners of Kazia Therapeutics Limited Concept (Monetary) For Period Credit ifrs-full:ProfitLoss
1063 Non-controlling interest Concept (Monetary) For Period Credit ifrs-full:ProfitLossAttributableToNoncontrollingInterests
1064 Loss after income tax attributable to the owners of Kazia Therapeutics Limited Concept (Monetary) For Period Credit ifrs-full:ProfitLossAttributableToOwnersOfParent
1065 Weighted average number of ordinary shares used in calculating basic earnings per share Concept (Shares) For Period ifrs-full:WeightedAverageShares
1066 Weighted average number of ordinary shares used in calculating diluted earnings per share Concept (Shares) For Period ifrs-full:AdjustedWeightedAverageShares
1067 Basic earnings per share Concept (Share) For Period ifrs-full:BasicEarningsLossPerShare
1068 Diluted earnings per share Concept (Share) For Period ifrs-full:DilutedEarningsLossPerShare
1069 1128 - Disclosure - Earnings per share - Additional Information (Detail) Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/DisclosureEarningsPerShareAdditionalInformation
1070 Earnings per share [table] Table

*

*

 ifrs-full:EarningsPerShareTable
1071 Classes of financial assets [axis] Axis ifrs-full:ClassesOfFinancialAssetsAxis
1072 Financial assets, class [member] Member ifrs-full:FinancialAssetsMember
1073 Unlisted options [member] Member kzia:UnlistedOptionsMember
1074 Listed options [member] Member kzia:ListedOptionMember
1075 Earnings per share [line items] LineItems ifrs-full:EarningsPerShareLineItems
1076 Number of unlisted convertible notes Concept (Shares) As Of kzia:NumberOfOrdinarySharesAvailableForConversion
1077 Face value of convertible notes Concept (Monetary) As Of Credit ifrs-full:OtherEquityInterest
1078 Number of options that have been excluded from the calculations as they were antidilutive Concept (Shares) For Period kzia:NumberOfAntidilutiveShareOptionsExcludedFromCalculationOfEarningsPerShare
1079 1129 - Disclosure - Share-based payments - Additional Information (Detail) Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/DisclosureSharebasedPaymentsAdditionalInformation
1080 Disclosure of terms and conditions of share-based payment arrangement [table] Table

*

*

 ifrs-full:DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable
1081 Types of share-based payment arrangements [axis] Axis ifrs-full:TypesOfSharebasedPaymentArrangementsAxis
1082 Share-based payment arrangements [member] Member ifrs-full:SharebasedPaymentArrangementsMember
1083 Tranche 9 [member] Member kzia:TrancheNineMember
1084 Tranche 10 [member] Member kzia:TrancheTenMember
1085 Disclosure of terms and conditions of share-based payment arrangement [line items] LineItems ifrs-full:DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems
1086 Employee remuneration expense Concept (Monetary) For Period Debit ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees
1087 Options expired Concept (Decimal) For Period ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement
1088 Weighted average remaining contractual life of outstanding share options Concept (Decimal) As Of ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions
1089 Number of options issued to employees Concept (Decimal) For Period ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
1090 Options vesting period Concept (Text/String) For Period ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement
1091 Options expiry period Concept (Text/String) For Period ifrs-full:DescriptionOfMaximumTermOfOptionsGrantedForSharebasedPaymentArrangement
1092 1130 - Disclosure - Share-based payments - Summary of share-based payments (Detail) Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/DisclosureSharebasedPaymentsSummaryOfSharebasedPayments
1093 Disclosure of terms and conditions of share-based payment arrangement [table] Table

*

*

 ifrs-full:DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable
1094 Types of share-based payment arrangements [axis] Axis ifrs-full:TypesOfSharebasedPaymentArrangementsAxis
1095 Share-based payment arrangements [member] Member ifrs-full:SharebasedPaymentArrangementsMember
1096 Tranche 1 [member] Member kzia:TrancheOneMember
1097 Tranche 2 [member] Member kzia:TrancheTwoMember
1098 Tranche 3 [member] Member kzia:TrancheThreeMember
1099 Tranche 4 [member] Member kzia:TrancheFourMember
1100 Tranche 5 [member] Member kzia:TrancheFiveMember
1101 Tranche 6 [member] Member kzia:TrancheSixMember
1102 Tranche 7 [member] Member kzia:TrancheSevenMember
1103 Tranche 8 [member] Member kzia:TrancheEightMember
1104 Tranche 9 [member] Member kzia:TrancheNineMember
1105 Tranche 10 [member] Member kzia:TrancheTenMember
1106 Tranche 11 [member] Member kzia:TrancheElevenMember
1107 Tranche 12 [member] Member kzia:TrancheTwelveMember
1108 Tranche 13 [member] Member kzia:TrancheThirteenMember
1109 Disclosure of terms and conditions of share-based payment arrangement [line items] LineItems ifrs-full:DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems
1110 Grant date Concept (Text/String) For Period ifrs-full:DateOfGrantOfSharebasedPaymentArrangement
1111 Expiry date Concept (Date) For Period kzia:ShareBasedPaymentArrangementOptionsExpiryDate
1112 Exercise price Concept (Monetary) For Period ifrs-full:ExercisePriceShareOptionsGranted
1113 Balance at the start of the year, share options Concept (Decimal) As Of ifrs-full:NumberOfOutstandingShareOptions
1114 Granted, share options Concept (Decimal) For Period ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
1115 Share Consolidation, share options Concept (Shares) For Period kzia:NumberOfShareOptionsConsolidated
1116 Exercised, share options Concept (Decimal) For Period ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement
1117 Forfeited on cessation of employment, share options Concept (Decimal) For Period kzia:NumberOfShareOptionsForfeitedOrExpiredInSharebasedPaymentArrangement
1118 Balance at the end of the year, share options Concept (Decimal) As Of ifrs-full:NumberOfOutstandingShareOptions
1119 Balance at the start of the year, Weighted average exercise price Concept (Monetary) As Of ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement
1120 Granted, Weighted average exercise price Concept (Monetary) For Period ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement
1121 Exercised, Weighted average exercise price Concept (Monetary) For Period ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement
1122 Forfeited on cessation of employment, Weighted average exercise price Concept (Monetary) For Period kzia:WeightedAverageExercisePriceOfShareOptionsForfeitedOrExpiredInSharebasedPaymentArrangement
1123 Balance at the end of the year, Weighted average exercise price Concept (Monetary) As Of ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement
1124 1131 - Disclosure - Share-based payments - Summary of valuation for each tranche of options (Detail) Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/DisclosureSharebasedPaymentsSummaryOfValuationForEachTrancheOfOptions
1125 Disclosure of terms and conditions of share-based payment arrangement [table] Table

*

*

 ifrs-full:DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable
1126 Types of share-based payment arrangements [axis] Axis ifrs-full:TypesOfSharebasedPaymentArrangementsAxis
1127 Share-based payment arrangements [member] Member ifrs-full:SharebasedPaymentArrangementsMember
1128 Tranche 1 [member] Member kzia:TrancheOneMember
1129 Tranche 2 [member] Member kzia:TrancheTwoMember
1130 Tranche 3 [member] Member kzia:TrancheThreeMember
1131 Tranche 4 [member] Member kzia:TrancheFourMember
1132 Tranche 5 [member] Member kzia:TrancheFiveMember
1133 Tranche 6 [member] Member kzia:TrancheSixMember
1134 Tranche 7 [member] Member kzia:TrancheSevenMember
1135 Tranche 8 [member] Member kzia:TrancheEightMember
1136 Tranche 9 [member] Member kzia:TrancheNineMember
1137 Tranche 10 [member] Member kzia:TrancheTenMember
1138 Tranche 11 [member] Member kzia:TrancheElevenMember
1139 Tranche 12 [member] Member kzia:TrancheTwelveMember
1140 Tranche 13 [member] Member kzia:TrancheThirteenMember
1141 Disclosure of terms and conditions of share-based payment arrangement [line items] LineItems ifrs-full:DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems
1142 Grant date Concept (Text/String) For Period ifrs-full:DateOfGrantOfSharebasedPaymentArrangement
1143 Expiry date Concept (Date) For Period kzia:ShareBasedPaymentArrangementOptionsExpiryDate
1144 Share price at Grant Date Concept (Share) For Period kzia:SharePricePerShare
1145 Exercise price Concept (Monetary) For Period ifrs-full:ExercisePriceShareOptionsGranted
1146 Volatility (%) Concept (Percent) For Period ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
1147 Remaining Option Life Concept (Decimal) For Period ifrs-full:DescriptionOfOptionLifeShareOptionsGranted
1148 Risk free Rate Concept (Percent) For Period ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
1149 Fair value per option Concept (Monetary) As Of Credit ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted
1150 1132 - Disclosure - Settlement of legal proceedings - Additional Information (Detail) Network

*

*

 http://www.kaziatherapeutics.com/taxonomy/role/DisclosureSettlementOfLegalProceedingsAdditionalInformation
1151 Disclosure Of Legal Proceedings [Table] Table

*

*

 kzia:DisclosureOfLegalProceedingsTable
1152 Categories of related parties [axis] Axis ifrs-full:CategoriesOfRelatedPartiesAxis
1153 Entity's total for related parties [member] Member ifrs-full:EntitysTotalForRelatedPartiesMember
1154 Noxopharm Limited [member] Member kzia:NoxopharmLimitedMember
1155 Disclosure of Legal Proceedings [line items] LineItems kzia:DisclosureOfLegalProceedingsLineItems
1156 Shares held in escrow Concept (Shares) As Of kzia:SharesHeldInEscrow
1157 Settlement of legal proceedings Concept (Monetary) For Period Credit kzia:ValueOfSettlementOfLegalProceedings
1158 Number of unlisted options Concept (Decimal) As Of kzia:NumberOfUnlistedOptions
1159 Excise price of unlisted options Concept (Share) For Period kzia:UnlistedOptionsExercisePrice
1160 Extinguishment of convertible notes Concept (Monetary) For Period Debit kzia:ExtinguishmentOfConvertibleNotes
1161 Cash payments Concept (Monetary) As Of Credit ifrs-full:AmountsPayableRelatedPartyTransactions
1162 Other income Concept (Monetary) For Period Credit ifrs-full:OtherIncome
1163 Change in equity Concept (Monetary) For Period Credit ifrs-full:ChangesInEquity

*

*